<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">102980</article-id><article-id pub-id-type="doi">10.7554/eLife.102980</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.102980.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Impaired fatty acid import or catabolism in macrophages restricts intracellular growth of <italic>Mycobacterium tuberculosis</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Simwela</surname><given-names>Nelson V</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4734-0518</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Jaecklein</surname><given-names>Eleni</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Sassetti</surname><given-names>Christopher M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6178-4329</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Russell</surname><given-names>David G</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9748-750X</contrib-id><email>dgr8@cornell.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05bnh6r87</institution-id><institution>Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University</institution></institution-wrap><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0464eyp60</institution-id><institution>Department of Microbiology, UMass Chan Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Worcester</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rp50x72</institution-id><institution>University of the Witwatersrand</institution></institution-wrap><country>South Africa</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rp50x72</institution-id><institution>University of the Witwatersrand</institution></institution-wrap><country>South Africa</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>13</day><month>03</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP102980</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-09-25"><day>25</day><month>09</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-10-11"><day>11</day><month>10</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.07.22.604660"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-12-16"><day>16</day><month>12</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.102980.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-02-20"><day>20</day><month>02</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.102980.2"/></event></pub-history><permissions><copyright-statement>© 2024, Simwela et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Simwela et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-102980-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-102980-figures-v1.pdf"/><abstract><p><italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>) infection of macrophages reprograms cellular metabolism to promote lipid retention. While it is clearly known that intracellular <italic>Mtb</italic> utilize host-derived lipids to maintain infection, the role of macrophage lipid processing on the bacteria’s ability to access the intracellular lipid pool remains undefined. We utilized a CRISPR-Cas9 genetic approach to assess the impact of sequential steps in fatty acid metabolism on the growth of intracellular <italic>Mtb</italic>. Our analyses demonstrate that macrophages that cannot either import, store, or catabolize fatty acids restrict <italic>Mtb</italic> growth by both common and divergent antimicrobial mechanisms, including increased glycolysis, increased oxidative stress, production of pro-inflammatory cytokines, enhanced autophagy, and nutrient limitation. We also show that impaired macrophage lipid droplet biogenesis is restrictive to <italic>Mtb</italic> replication, but increased induction of the same fails to rescue <italic>Mtb</italic> growth. Our work expands our understanding of how host fatty acid homeostasis impacts <italic>Mtb</italic> growth in the macrophage.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>tuberculosis</kwd><kwd>mycobacterium</kwd><kwd>macrophage</kwd><kwd>lipid metabolism</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>AI155319</award-id><principal-award-recipient><name><surname>Russell</surname><given-names>David G</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>AI162598</award-id><principal-award-recipient><name><surname>Russell</surname><given-names>David G</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>OD032135</award-id><principal-award-recipient><name><surname>Russell</surname><given-names>David G</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>T32AI007349</award-id><principal-award-recipient><name><surname>Jaecklein</surname><given-names>Eleni</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Mueller Health Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Russell</surname><given-names>David G</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Prevention of either lipid uptake or lipid catabolism in infected macrophages restricts the ability of <italic>Mycobacterium tuberculosis</italic> to grow inside these cells.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p><italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>), the causative agent of tuberculosis (TB), has caused disease and death in humans for centuries (<xref ref-type="bibr" rid="bib58">WHO, 2023</xref>). <italic>Mtb</italic> primarily infects macrophages in the lung (<xref ref-type="bibr" rid="bib8">Cohen et al., 2018</xref>; <xref ref-type="bibr" rid="bib60">Wolf et al., 2007</xref>), wherein the bacterium relies on host-derived fatty acids and cholesterol for the synthesis of its lipid-rich cell wall and to produce energy and virulence factors (<xref ref-type="bibr" rid="bib43">Peyron et al., 2008</xref>; <xref ref-type="bibr" rid="bib48">Russell et al., 2009</xref>; <xref ref-type="bibr" rid="bib53">Singh et al., 2012</xref>; <xref ref-type="bibr" rid="bib12">Daniel et al., 2011</xref>; <xref ref-type="bibr" rid="bib36">Muñoz-Elías and McKinney, 2005</xref>; <xref ref-type="bibr" rid="bib40">Pandey and Sassetti, 2008</xref>; <xref ref-type="bibr" rid="bib5">Brzostek et al., 2009</xref>). Within the lung microenvironment, resident alveolar macrophages preferentially oxidize fatty acids and are more permissive to <italic>Mtb</italic> growth while recruited interstitial macrophages are more glycolytic and restrictive of <italic>Mtb</italic> replication (<xref ref-type="bibr" rid="bib21">Huang et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Pisu et al., 2020</xref>; <xref ref-type="bibr" rid="bib45">Pisu et al., 2021</xref>). Globally, <italic>Mtb</italic> infection modifies macrophage metabolism in a manner that enhances its survival. <italic>Mtb</italic>-infected macrophages shift their mitochondrial substrate preference to exogenous fatty acids, which drives the formation of foamy macrophages that are laden with cytosolic lipid droplets (<xref ref-type="bibr" rid="bib43">Peyron et al., 2008</xref>; <xref ref-type="bibr" rid="bib48">Russell et al., 2009</xref>; <xref ref-type="bibr" rid="bib11">Cumming et al., 2018</xref>; <xref ref-type="bibr" rid="bib53">Singh et al., 2012</xref>; <xref ref-type="bibr" rid="bib46">Podinovskaia et al., 2013</xref>). Foamy macrophages are found in abundance in the central and inner layers of granulomas, a common histopathological feature of human TB (<xref ref-type="bibr" rid="bib48">Russell et al., 2009</xref>; <xref ref-type="bibr" rid="bib23">Kim et al., 2010</xref>). Interference with key regulators of lipid homeostasis, such as the miR-33 and the transcription factors peroxisome proliferator-activated receptor α (PPARα) and PPAR-γ, enhances macrophage control of <italic>Mtb</italic> (<xref ref-type="bibr" rid="bib24">Kim et al., 2017</xref>; <xref ref-type="bibr" rid="bib1">Almeida et al., 2009</xref>; <xref ref-type="bibr" rid="bib39">Ouimet et al., 2016</xref>). Moreover, compounds that modulate lipid metabolism such as the antidiabetic drug metformin and some cholesterol-lowering drugs are under investigation for host-directed therapeutics (HDTs) against <italic>Mtb</italic> (<xref ref-type="bibr" rid="bib41">Parihar et al., 2014</xref>; <xref ref-type="bibr" rid="bib54">Singhal et al., 2014</xref>). Although the dependence of intracellular <italic>Mtb</italic> on host fatty acids and cholesterol is well documented (<xref ref-type="bibr" rid="bib59">Wilburn et al., 2018</xref>), the impact of specific aspects of macrophage lipid metabolism on the bacteria remains opaque. In <italic>Mtb</italic>-infected foamy macrophages, bacteria containing phagosomes are found in close apposition to intracellular lipid droplets (<xref ref-type="bibr" rid="bib43">Peyron et al., 2008</xref>). It is believed that the bacterial induction of a foamy macrophage phenotype in host cells results in a steady supply of lipids that addresses the bacteria’s nutritional requirements (<xref ref-type="bibr" rid="bib43">Peyron et al., 2008</xref>; <xref ref-type="bibr" rid="bib48">Russell et al., 2009</xref>; <xref ref-type="bibr" rid="bib53">Singh et al., 2012</xref>; <xref ref-type="bibr" rid="bib12">Daniel et al., 2011</xref>). In fact, intracellular <italic>Mtb</italic> has been shown to import fatty acids from host lipid droplet- derived triacylglycerols (<xref ref-type="bibr" rid="bib12">Daniel et al., 2011</xref>). However, other studies indicate that macrophage lipid droplet formation in response to <italic>Mtb</italic> infection can lead to the induction of a protective, antimicrobial response (<xref ref-type="bibr" rid="bib27">Knight et al., 2018</xref>). <italic>Mtb</italic> appears unable to acquire host lipids when lipid droplets are induced by stimulation with interferon gamma (IFN-γ) (<xref ref-type="bibr" rid="bib27">Knight et al., 2018</xref>). Moreover, there is some evidence that lipid droplets can be sites for the production of host-protective pro-inflammatory eicosanoids (<xref ref-type="bibr" rid="bib27">Knight et al., 2018</xref>; <xref ref-type="bibr" rid="bib12">Daniel et al., 2011</xref>). Lipid droplets can also act as innate immune hubs against intracellular bacterial pathogens by clustering antibacterial proteins (<xref ref-type="bibr" rid="bib4">Bosch et al., 2020</xref>). Inhibition of macrophage fatty acid oxidation by knocking out mitochondrial carnitine palmitoyl transferase 2 (CPT2) or using chemical inhibitors of CPT2 also restrict intracellular growth of <italic>Mtb</italic> (<xref ref-type="bibr" rid="bib7">Chandra et al., 2020</xref>; <xref ref-type="bibr" rid="bib21">Huang et al., 2018</xref>). These data demonstrate that modulation of the different stages in lipid metabolism inside <italic>Mtb</italic>-infected macrophages can result in conflicting outcomes.</p><p>We carried out a candidate-based, CRISPR-mediated knockout of lipid import and metabolism genes in macrophages to determine their roles in intracellular growth of <italic>Mtb</italic>. By targeting genes involved in fatty acid import, sequestration, and metabolism in Hoxb8-derived conditionally immortalized murine macrophages (<xref ref-type="bibr" rid="bib26">Kiritsy et al., 2021</xref>), we show that impairing lipid homeostasis in macrophages at different steps in the process negatively impacts the growth of intracellular <italic>Mtb</italic>, albeit to differing degrees. The impact on <italic>Mtb</italic> growth in the mutant macrophages was mediated through different mechanisms despite some common antimicrobial effectors. <italic>Mtb</italic>-infected macrophages deficient in the import of long-chain fatty acids increased the production of pro-inflammatory markers such as interleukin 1β (IL-1β). In contrast, ablation of lipid droplet biogenesis and fatty acid oxidation increased the production of reactive oxygen species (ROS) and limited the bacteria’s access to nutrients. We also found that suppression of <italic>Mtb</italic> growth in macrophages that are unable to produce lipid droplets could not be rescued by exogeneous addition of fatty acids, indicating that this is not purely nutritional restriction. Our data indicate that interference of lipid metabolism in macrophages leads to suppression of <italic>Mtb</italic> growth via multiple routes.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Knockout of fatty acid import and metabolism genes restricts <italic>Mtb</italic> growth in macrophages</title><p>To apply a holistic approach to assessing the role(s) of fatty acid metabolism on the intracellular growth of <italic>Mtb</italic>, we used a CRISPR genetic approach to knockout genes involved in lipid import (CD36, SLC27A1), lipid droplet formation (PLIN2), and fatty acid oxidation (CPT1A, CPT2) in murine primary macrophages (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Deletion of CD36 or CPT2 in mouse macrophages has been shown to impair intracellular growth of <italic>Mtb</italic> (<xref ref-type="bibr" rid="bib20">Hawkes et al., 2010</xref>; <xref ref-type="bibr" rid="bib7">Chandra et al., 2020</xref>). But the role of specialized long-chain fatty acid transporters (SLC27A1-6) on <italic>Mtb</italic> growth in macrophages is uncharacterized. SLC27A1 and SLC27A4 are the most abundant fatty acid transporter isoforms in macrophages (<xref ref-type="bibr" rid="bib38">Nishiyama et al., 2018</xref>). PLIN2, or adipophilin, is known to be required for lipid droplet formation (<xref ref-type="bibr" rid="bib42">Paul et al., 2008</xref>; <xref ref-type="bibr" rid="bib29">Larigauderie et al., 2004</xref>). Five isoforms of mammalian perilipins (PLIN) are involved in lipid droplet biogenesis among which PLIN2 is the dominant isoform expressed in macrophages (<xref ref-type="bibr" rid="bib27">Knight et al., 2018</xref>). However, macrophages derived from <italic>Plin2</italic><sup>-/-</sup> mice show no defects in the production of lipid droplets nor do they impair intracellular growth of <italic>Mtb</italic> (<xref ref-type="bibr" rid="bib27">Knight et al., 2018</xref>). We targeted each of these genes with at least two sgRNAs in Hoxb8 Cas9<sup>+</sup> conditionally immortalized myeloid progenitors (<xref ref-type="bibr" rid="bib26">Kiritsy et al., 2021</xref>) to generate a panel of mutants that were deficient in the following candidates of interest; <italic>Slc27a1</italic><sup>-/-</sup>p<italic>lin2<sup>-</sup></italic><sup>/-</sup>, <italic>Cd36<sup>-</sup></italic><sup>/-</sup>, <italic>Cpt1a</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup>. Each individual sgRNA achieved &gt;85% CRISPR-mediated deletion efficiency for all the five genes as analyzed by the Inference for CRISPR Edits (ICE) tool (<xref ref-type="bibr" rid="bib9">Conant et al., 2022</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). We verified the protein knockout phenotypes by flow cytometry and western blot analysis of differentiated macrophages derived from the CRISPR-deleted Hoxb8 myeloid precursors (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Knockout of fatty acid import and metabolism genes restricts <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>) growth in macrophages.</title><p>(<bold>A</bold>) Schematic of lipid import and metabolism genes in macrophages. Genes targeted for CRISPR-Cas9-mediated knockout are highlighted in red. (<bold>B</bold>) Scramble or indicated mutant macrophages were infected with the <italic>Mtb</italic> Erdman strain at a multiplicity of infection (MOI) of 0.4. Intracellular <italic>Mtb</italic> growth was measured by plating and counting colony-forming units (CFUs) in lysed macrophages 5 days post infection (PI). (<bold>C</bold>) CFUs from lysed macrophages were also plated on day 0, 3 hours PI to measure bacterial uptake differences. n = 6 biological replicates; ****p&lt;0.0001, one-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values  ± SD.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig1">Figure 1B and C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102980-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Flow cytometry and western blot analysis of CRISPR knockout macrophages.</title><p>(<bold>A–E</bold>) Western blot and flow cytometry analysis of protein depletion in fatty acid import and metabolism genes in macrophages derived from Hoxb8 parental lines (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Each gene was targeted with at least two sgRNAs; PLIN2 (<bold>A</bold>), SLC27A1 (<bold>B</bold>), CD36 (<bold>C</bold>), CPT1A (<bold>D</bold>), and CPT2 (<bold>E</bold>).</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Original western blots for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A, B, D and E</xref>, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-102980-fig1-figsupp1-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A, B, D and E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-102980-fig1-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Lipid droplet formation and fatty acid oxidation in <italic>Plin2</italic><sup>-/-</sup> and <italic>Cpt2</italic><sup>-/-</sup> macrophages.</title><p>(<bold>A</bold>) Phenotypic characterization of lipid droplet biogenesis in <italic>Plin2</italic><sup>-/-</sup> macrophages. Uninfected macrophages were supplemented with 400 μM oleate for 24 hours. Cells were fixed for 20 minutes and stained for lipid droplet inclusions using the Bodipy 493/503 dye. DAPI was used as a counterstain to detect nuclei. (<bold>B,C</bold>) Seahorse fatty acid oxidation analyses of uninfected scramble or <italic>Cpt2</italic><sup>-/-</sup> macrophages. Cells were cultured in substrate-limiting conditions for 24 hours and supplied with exogenous palmitate. Oxygen consumption rates (OCRs) were measured as in the Cell Mito Stress Test Kit (Agilent). Oligo, oligomycin; FCCP, fluoro-carbonyl cyanide phenylhydrazone; Rot/A, rotenone and antimycin A; BSA, bovine serum albumin; Eto, etomoxir. n = 3 biological replicates; **p&lt;0.01, one-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values  ± SD.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B and C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102980-fig1-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig1-figsupp2-v1.tif"/></fig></fig-group><p>To confirm certain knockout phenotypes functionally, we checked lipid droplet biogenesis in <italic>Plin2</italic><sup>-/-</sup> macrophages in comparison to macrophages transduced with a non-targeting scramble sgRNA by confocal microscopy of BODIPY-stained cells. Cells were cultured for 24 hours in the presence of exogenous oleate to enhance the formation of lipid droplets (<xref ref-type="bibr" rid="bib32">Listenberger and Brown, 2007</xref>). We observed a complete absence of lipid droplet formation in <italic>Plin2</italic><sup>-/-</sup> macrophages compared to controls (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). This is contrary to previous observations in macrophages derived from PLIN2 knockout mice, which were reported to have no defect in lipid droplet formation (<xref ref-type="bibr" rid="bib27">Knight et al., 2018</xref>). We also assessed the ability of <italic>Cpt2</italic><sup>-/-</sup> macrophages to oxidize fatty acids using the Agilent Seahorse XF Palmitate Oxidation Stress Test. Scrambled sgRNA and <italic>Cpt2</italic><sup>-/-</sup> macrophages were cultured in substrate-limiting conditions and supplied with either bovine serum albumin (BSA) or BSA-conjugated palmitate. As shown in <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>, control macrophages were able to utilize and oxidize palmitate in substrate-limiting conditions indicated by a significant increase in oxygen consumption rates (OCRs) in contrast to cells supplied with BSA alone. Addition of the CPT1A inhibitor, etomoxir, inhibited the cell’s ability to use palmitate in these conditions (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>). CPT2 knockout in <italic>Cpt2</italic><sup>-/-</sup> macrophages impaired the cell’s ability to oxidize palmitate to a degree comparable to etomoxir treatment as evidenced by baseline OCRs compared to scrambled sgRNA control (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>).</p><p>We then assessed the different knockout mutant macrophages in their ability to support the intracellular growth of <italic>Mtb</italic>. We infected macrophages with <italic>Mtb</italic> Erdman at a multiplicity of infection (MOI) of 0.4 and assessed intracellular bacterial growth rates by counting colony-forming units (CFUs) 5 days post infection. All the five mutant macrophages significantly impaired <italic>Mtb</italic> growth rates compared to scrambled sgRNA as assessed by CFUs counts on day 5 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages displayed the strongest growth restriction phenotypes while <italic>Cd36<sup>-/-</sup></italic>macrophages had a moderate, but significant, impact on <italic>Mtb</italic> growth. In parallel, we quantified intracellular bacteria on day 0, 3 hours post infection (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), to ascertain that subsequent differences on day 5 were not due to disparities in initial bacterial uptake. The moderate growth restriction phenotypes of <italic>Cd36</italic><sup>-/-</sup> macrophages were consistent with previous findings, which reported a similar impact on <italic>Mtb</italic> and <italic>M. marinum</italic> growth in macrophages derived from <italic>Cd36</italic><sup>-/-</sup> mice (<xref ref-type="bibr" rid="bib20">Hawkes et al., 2010</xref>). Impaired growth of <italic>Mtb</italic> in <italic>Cpt1a</italic><sup>-/-</sup> and <italic>Cpt2</italic><sup>-/-</sup> macrophages is also consistent with previous reports that genetic and chemical inhibition of fatty acid oxidation is detrimental to the growth of <italic>Mtb</italic> within macrophages (<xref ref-type="bibr" rid="bib21">Huang et al., 2018</xref>; <xref ref-type="bibr" rid="bib7">Chandra et al., 2020</xref>).</p></sec><sec id="s2-2"><title><italic>Mtb</italic>-infected macrophages with impaired fatty acid import and metabolism display altered mitochondrial metabolism and elevated glycolysis</title><p>Impairment of fatty acids metabolism by SLC27A1 knockout in macrophages rewires their substrate bias from fatty acids to glucose (<xref ref-type="bibr" rid="bib22">Johnson et al., 2016</xref>). We reasoned that deletion of genes required for downstream processing of lipids (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) could also reprogram macrophages and increase glycolysis, which could, in part, explain bacterial growth restriction. We analyzed the metabolic states of three knockout macrophages (<italic>Slc27a1</italic><sup>-/-</sup>, <italic>Plin2</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup>) in uninfected and <italic>Mtb</italic>-infected conditions by monitoring OCRs and extracellular acidification rates (ECARs) using the Agilent Mito and Glucose Stress Test kits. All three mutant uninfected macrophages displayed reduced mitochondrial respiration as evidenced by lower basal and spare respiratory capacity (SRC) compared to scrambled sgRNA controls (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A and B</xref>). <italic>Mtb</italic> infection proportionally reduced basal and SRC rates across all the mutant macrophages and scrambled controls (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>) compared to uninfected macrophages, which is consistent with previous findings (<xref ref-type="bibr" rid="bib11">Cumming et al., 2018</xref>). <italic>Plin2</italic><sup>-/-</sup> macrophages displayed the most marked reduction in mitochondrial activity in both uninfected and infected conditions, while <italic>Slc27a1</italic><sup>-/-</sup> macrophages were the least affected (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). As reported previously (<xref ref-type="bibr" rid="bib22">Johnson et al., 2016</xref>), uninfected <italic>Slc27a1</italic><sup>-/-</sup> macrophages were more glycolytically active with higher basal and spare glycolytic capacity (SGC) compared to scrambled controls (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C and D</xref>). Uninfected <italic>Plin2</italic><sup>-/-</sup> and <italic>Cpt2</italic><sup>-/-</sup> macrophages were also more glycolytically active, but to a greater degree than <italic>Slc27a1</italic><sup>-/-</sup> (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C and D</xref>). <italic>Mtb</italic> infection increased the glycolytic capacity of all the three mutant macrophages (<xref ref-type="fig" rid="fig2">Figure 2C and D</xref>). Overall, <italic>Plin2</italic><sup>-/-</sup> macrophages exhibited the highest glycolytic capacity (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). Our data indicates that impairment of fatty acid metabolism at different steps significantly impacts mitochondrial respiration and reprograms cells toward glycolysis. Increased glycolytic flux in macrophages has been linked to the control of intracellular <italic>Mtb</italic> growth (<xref ref-type="bibr" rid="bib16">Gleeson et al., 2016</xref>; <xref ref-type="bibr" rid="bib51">Shi et al., 2015</xref>). Metabolic realignment as a consequence of interference with lipid homeostasis, which results in enhanced glycolysis may contribute to <italic>Mtb</italic> growth restriction in these mutant macrophages.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>)-infected macrophages with impaired fatty acid import and metabolism display reduced mitochondrial activities and are more glycolytic.</title><p>(<bold>A</bold>) Seahorse flux analyses of scramble or <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages infected with <italic>Mtb</italic> Erdman strain at a multiplicity of infection (MOI) of 1 24 hours post infection. Oxygen consumption rates (OCRs) were measured using the Cell Mito Stress Test Kit (Agilent). Oligo, oligomycin; FCCP, fluoro-carbonyl cyanide phenylhydrazone; Rot/A, rotenone and antimycin A. (<bold>B</bold>) Comparison of basal respiration and spare respiratory capacity (SRC) from (A). SRC was calculated by subtracting the normalized maximal OCR from basal OCR. n = 3 biological replicates (two technical repeats per replicate); ****p&lt;0.0001, one-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. (<bold>C</bold>) Extracellular acidification rates (ECARs) of scramble or <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages infected with <italic>Mtb</italic> as in (A). ECARs were measured using the Agilent Seahorse Glycolysis Stress Test kit. 2DG, 2-deoxy-<sc>d</sc>-glucose. (<bold>D</bold>) Comparison of basal glycolysis and spare glycolytic capacity (SGC) in the indicated mutant macrophages. SGC was calculated as SRC above. n = 3 biological replicates (two technical repeats per replicate); *p&lt;0.05, ****p&lt;0.0001, one-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig2">Figure 2A–D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102980-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Flux analyses of mitochondrial activities and glycolysis in <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages.</title><p>(<bold>A,B</bold>) Seahorse flux analyses in uninfected scramble or <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages using the Cell Mito Stress Kit as in <xref ref-type="fig" rid="fig2">Figure 2A and B</xref>. (<bold>C,D</bold>) Seahorse flux analyses in uninfected scramble or <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages using the Glycolysis Stress Test kit as in <xref ref-type="fig" rid="fig2">Figure 2C and D</xref>.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102980-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig2-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Knockout of lipid import and metabolism genes in macrophages activates AMPK and stabilizes HIF1α</title><p><italic>Mtb</italic> infection is known to induce increased glycolysis or the ‘Warburg effect’ in macrophages, mouse lungs, and human TB granulomas (<xref ref-type="bibr" rid="bib51">Shi et al., 2015</xref>; <xref ref-type="bibr" rid="bib16">Gleeson et al., 2016</xref>; <xref ref-type="bibr" rid="bib3">Belton et al., 2016</xref>). Several studies have demonstrated that the Warburg effect is mediated by the master transcription factor hypoxia-inducible factor 1 (HIF1) (<xref ref-type="bibr" rid="bib10">Courtnay et al., 2015</xref>). During <italic>Mtb</italic> infection, HIF1 is activated by the production of ROS, tricarboxylic cycle (TCA) intermediates and hypoxia in the cellular microenvironments as a consequence of altered metabolic activities and increased immune cell functions (<xref ref-type="bibr" rid="bib31">Li et al., 2024</xref>; <xref ref-type="bibr" rid="bib51">Shi et al., 2015</xref>; <xref ref-type="bibr" rid="bib16">Gleeson et al., 2016</xref>; <xref ref-type="bibr" rid="bib3">Belton et al., 2016</xref>). We assessed HIF1 stability in the three mutant macrophage lineages (<italic>Slc27a1</italic><sup>-/-</sup>, <italic>Plin2</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup>) by monitoring total HIF1α protein levels by western blot, having confirmed that they were all more glycolytically active than the scrambled controls (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Indeed, all the three mutant macrophages displayed significantly higher amounts of total HIF1α compared to scrambled controls after <italic>Mtb</italic> infection for 48 hours (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>). <italic>Slc27a1</italic><sup>-/-</sup>, <italic>Plin2<sup>-</sup></italic><sup>/-</sup> macrophages had increased levels of total HIF1α even in uninfected states (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>). We also checked the phosphorylation status of the adenosine monophosphate kinase (AMPK), a master regulator of cell energy homeostasis (<xref ref-type="bibr" rid="bib15">Garcia and Shaw, 2017</xref>), in the mutant macrophages since Seahorse flux analyses indicated that they had impaired mitochondrial activities (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Western blot analysis revealed that in both <italic>Mtb</italic>-infected and uninfected conditions, impaired fatty acid metabolism in the mutant macrophages correlated with increased activation of AMPK as indicated by higher levels of phosphorylated AMPK compared to scramble (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C and D</xref>). Interestingly, total AMPK was also increased, at least in <italic>Slc27a1</italic><sup>-/-</sup>and <italic>Plin2<sup>-/-</sup></italic> macrophages, in both uninfected and <italic>Mtb</italic>-infected conditions (<xref ref-type="fig" rid="fig3">Figure 3C and E</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C and D</xref>). These data point to a metabolic reprogramming of cells through activation of HIF1α and AMPK to promote glycolysis. In energetically stressed cellular environments, activated AMPK promotes catabolic processes such as autophagy to maintain nutrient supply and energy homeostasis (<xref ref-type="bibr" rid="bib15">Garcia and Shaw, 2017</xref>). Autophagy is also an innate immune defense mechanism against intracellular <italic>Mtb</italic> in macrophages (<xref ref-type="bibr" rid="bib19">Gutierrez et al., 2004</xref>). We examined the levels of autophagic flux in the mutant macrophages by monitoring LC3I to LC3II conversion by western blot and by qPCR analysis of selected autophagy genes (AMBRA1, ATG7, MAP1LC3B and ULK1). We observed an increase in autophagic flux by western blot analysis of LC3II/LC3I ratios in <italic>Mtb</italic>-infected <italic>Slc27a1</italic><sup>-/-</sup> and <italic>Cpt2</italic><sup>-/-</sup> macrophages (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A–C</xref>). <italic>Cpt2</italic><sup>-/-</sup> macrophages were more autophagic even in uninfected conditions (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A–C</xref>). Meanwhile, our qPCR analysis also revealed that the four autophagy genes were upregulated in both <italic>Mtb</italic>-infected and uninfected conditions in all the three mutants (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D and E</xref>). These data suggest that impaired fatty acid import and metabolism in macrophages could be restricting <italic>Mtb</italic> growth by promoting autophagy. These data agree with previous observations that inhibition of fatty acid oxidation enhances macrophage xenophagic activity, which leads to improved control of <italic>Mtb</italic> (<xref ref-type="bibr" rid="bib7">Chandra et al., 2020</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Knockout of fatty acid import and metabolism genes in macrophages activate AMPK and stabilizes HIF1α.</title><p>(<bold>A</bold>) Western blot analysis of HIF1α in uninfected and <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>)-infected scramble or <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages. In <italic>Mtb</italic>-infected conditions, cells were infected with the bacteria at a multiplicity of infection (MOI) of 1 for 48 hours before preparation of cell lysates. (<bold>B</bold>) Quantification of relative expression of HIF1α in (A) and in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref> normalized to β-actin; n = 3 biological replicates. *p&lt;0.05; ***p&lt;0.001, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. (<bold>C</bold>) Western blot analysis of total and phosphorylated AMPK in uninfected and <italic>Mtb</italic>-infected scramble or <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> <italic>macrophages</italic>. Cell lysates were prepared as in (<bold>A</bold>). (<bold>D, E</bold>) Quantification of relative expression of pAMPK and AMPK in (<bold>C</bold>) and in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C and D</xref> normalized to β-actin; n = 3 biological replicates. **p&lt;0.01; ***p&lt;0.001, ****p&lt;0.0001, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Original western blots for <xref ref-type="fig" rid="fig3">Figure 3A and C</xref>, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-102980-fig3-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig3">Figure 3A and C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-102980-fig3-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig3">Figure 3B, D, and E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102980-fig3-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Replicate western blot analyses of HIF1α (<bold>A, B</bold>), AMPK and pAMPK (<bold>C, D</bold>) in uninfected and <italic>Mtb-</italic>infected scramble or <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages as in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Original western blots for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–D</xref>, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-102980-fig3-figsupp1-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-102980-fig3-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Increased autophagy in <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages.</title><p>(<bold>A, B</bold>) Independent western blot analyzes of autophagic LC3I to LC3II conversion in uninfected and <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>)-infected scramble or <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages. (<bold>C</bold>) Densitometry quantification of LC3I to LC3II turnover ratios (LC3II/LC3I ratio) in (<bold>A</bold>) and (<bold>B</bold>) after normalization to β-actin; n = 2 biological replicates. *p&lt;0.05; **p&lt;0.01, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. (<bold>D, E</bold>) qPCR analysis of the indicated autophagy genes in uninfected (<bold>D</bold>) and <italic>Mtb</italic>-infected (<bold>E</bold>) scramble or <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages. The <italic>Mtb Erdman</italic> strain was used for bacterial infections. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values  ± SD.</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Original western blots for <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A and B</xref>, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-102980-fig3-figsupp2-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig3s2sdata2"><label>Figure 3—figure supplement 2—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A and B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-102980-fig3-figsupp2-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s2sdata3"><label>Figure 3—figure supplement 2—source data 3.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C, D, and E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102980-fig3-figsupp2-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig3-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Exogenous oleate fails to rescue the <italic>Mtb icl1-</italic>deficient mutant in <italic>Slc27a1</italic><sup>-/-</sup>, <italic>Plin2</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages</title><p>The mycobacterial isocitrate lyase (<italic>icl1</italic>) acts as an isocitrate lyase in the glyoxylate shunt and as a methyl-isocitrate lyase in the methyl-citrate cycle (MCC) (<xref ref-type="bibr" rid="bib17">Gould et al., 2006</xref>; <xref ref-type="bibr" rid="bib35">McKinney et al., 2000</xref>). <italic>Mtb</italic> uses the MCC to convert propionyl CoA originating from the breakdown of cholesterol rings and β-oxidation of odd chain fatty acids into succinate and pyruvate, which are eventually assimilated into the tricarboxylic cycle (TCA) (<xref ref-type="bibr" rid="bib37">Muñoz-Elías et al., 2006</xref>; <xref ref-type="bibr" rid="bib18">Griffin et al., 2012</xref>). The buildup of propionyl CoA is toxic to <italic>Mtb</italic> and the bacteria relies on the MCC together with the incorporation of propionyl CoA to methyl-branched lipids in the cell wall as an internal detoxification system (<xref ref-type="bibr" rid="bib37">Muñoz-Elías et al., 2006</xref>; <xref ref-type="bibr" rid="bib49">Savvi et al., 2008</xref>). <italic>Mtb</italic> propionyl CoA toxicity is, in part, due to a cellular imbalance between propionyl CoA and acetyl CoA as an accumulation of the former or paucity of the latter results in the propionyl CoA-mediated inhibition of pyruvate dehydrogenase (<xref ref-type="bibr" rid="bib30">Lee et al., 2013</xref>). Consequently, <italic>Mtb icl1</italic>-deficient mutants (<italic>Mtb Δicl1</italic>) are unable to grow in media supplemented with cholesterol or propionate, or intracellularly in macrophages (<xref ref-type="bibr" rid="bib30">Lee et al., 2013</xref>). However, this growth inhibition could be rescued both in culture and in macrophages by exogenous supply of acetate or even chain fatty acids, which can be oxidized to acetyl-CoA (<xref ref-type="bibr" rid="bib30">Lee et al., 2013</xref>). We took advantage of this metabolic knowledge to assess whether exogenous addition of the even chain fatty acid oleate can rescue the intracellular growth of <italic>Mtb Δicl1</italic> mutants in our CRISPR knockout macrophages. Scrambled controls, <italic>Slc27a1</italic><sup>-/-</sup>, <italic>Plin2</italic><sup>-/-</sup>, and <italic>Cpt2<sup>-</sup></italic><sup>/-</sup> macrophages in normal macrophage media or media supplemented with oleate were infected with an <italic>Mtb Δicl1</italic> strain expressing mCherry at MOI 5. Bacterial growth measured by mCherry expression was recorded 5 days post infection. Consistent with previous observations (<xref ref-type="bibr" rid="bib30">Lee et al., 2013</xref>), the <italic>Mtb Δicl1</italic> mutant failed to replicate in both mutant and scramble macrophages that were grown in normal macrophage media as evidenced by baseline mCherry fluorescence (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Oleate supplementation successfully rescued the <italic>Mtb Δicl1</italic> mutant in scrambled control macrophages. However, the growth restriction of the <italic>Mtb Δicl1</italic> strain could not be alleviated by exogenous addition of oleate to the mutant macrophages (<italic>Slc27a1</italic><sup>-/-</sup>, <italic>Plin2</italic><sup>-/-</sup>, and <italic>Cpt2<sup>-</sup></italic><sup>/-</sup>) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). These data suggest that impaired import (<italic>Slc27a1</italic><sup>-/-</sup>), sequestration (<italic>Plin2</italic><sup>-/-</sup>), or β-oxidation of fatty acids (<italic>Cpt2</italic><sup>-/-</sup>) blocks <italic>Mtb</italic>’s ability to access and use cellular lipids.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Supplementation with exogenous oleate fails to rescue the <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>) Δicl1 mutant in <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages.</title><p>(<bold>A</bold>) Scramble or indicated mutant macrophages were infected with the <italic>Mtb</italic> H37Rv Δicl1 mutant expressing mCherry at a multiplicity of infection (MOI) of 5. Oleate supplementation (400 μM) was commenced 24 hours before infection in the treatment group, removed during <italic>Mtb</italic> infection and readded 3 hours post infection for the entire duration of the experiment. Growth kinetics of <italic>Mtb</italic> were measured by monitoring mCherry fluorescence using a plate reader. n = 4 biological replicates; ****p&lt;0.0001, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. (<bold>B</bold>) Uninfected scramble or <italic>Slc27a1</italic><sup>-/-</sup> and <italic>Cpt2</italic><sup>-/-</sup> macrophages were supplemented with 400 μM oleate for 24 hours. Cells were then fixed for 20 minutes and stained for lipid droplet inclusions using the Bodipy 493/503 dye. DAPI was used as a counterstain to detect nuclei.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig4">Figure 4A</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102980-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig4-v1.tif"/></fig><p>Oleate supplementation in macrophages induces the formation of lipid droplets, and we were able to confirm the inability to produce lipid droplets in <italic>Plin2</italic><sup>-/-</sup> macrophages using this approach (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). As an indirect measure to track the fate of supplemented oleate in the mutant macrophages, we monitored lipid droplet biogenesis in <italic>Slc27a1</italic><sup>-/-</sup> and <italic>Cpt2</italic><sup>-/-</sup> macrophages to check if the inability to rescue the <italic>Mtb Δicl1</italic> impaired growth phenotypes in these mutant macrophages could be possibly related to disruptions in lipid droplet formation. Confocal analysis of BODIPY-stained cells upon oleate supplementation revealed that <italic>Slc27a1</italic><sup>-/-</sup> macrophages also fail to generate lipid droplets (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). In contrast, <italic>Cpt2<sup>-/-</sup></italic> macrophages produced more and larger lipid droplets in comparison to scrambled controls (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). These data suggest that the inhibition of <italic>Mtb</italic> growth in these mutant macrophages is not merely through limitation of access to fatty acid nutrients.</p></sec><sec id="s2-5"><title>Dual RNA sequencing to identify host and bacterial determinants of <italic>Mtb</italic> restriction in mutant macrophage lineages</title><p>We performed RNA sequencing of both host and bacteria in <italic>Mtb</italic>-infected mutant macrophages as a preliminary step in the identification of pathways restricting bacterial growth. We infected scrambled controls, <italic>Slc27a1</italic><sup>-/-</sup>, <italic>Plin2</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages with the <italic>Mtb</italic> smyc’::mCherry strain for 4 days and processed the samples for dual RNA sequencing as previously described (<xref ref-type="bibr" rid="bib52">Simwela et al., 2024</xref>). Principal component analysis (PCA) of host transcriptomes revealed a clustering of all the three mutant macrophages away from scrambled controls (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Interestingly, there was a separation in transcriptional responses between the three mutant macrophages as <italic>Cpt2</italic><sup>-/-</sup> and <italic>Plin2</italic><sup>-/-</sup> macrophages clustered closer together and more distant from <italic>Slc27a1</italic><sup>-/-</sup> (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Overall, using an adjusted p-value&lt;0.05 and absolute log<sub>2</sub> fold change &gt;1.2, we identified 900 genes that were differentially expressed (DE) in <italic>Plin2</italic><sup>-/-</sup> macrophages (589 up, 311 down), 817 genes that were DE in <italic>Slc27a1</italic><sup>-/-</sup> macrophages (501 up, 315 down), and 189 genes that were DE in <italic>Cpt2</italic><sup>-/-</sup> (124 up, 65 down) (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, <xref ref-type="fig" rid="fig5">Figure 5B</xref>). Consistent with the PCA, Venn diagram of the DE genes (<xref ref-type="fig" rid="fig5">Figure 5B</xref>) indicated divergent responses in the three mutant macrophage populations. We performed pathway enrichment analysis (<xref ref-type="bibr" rid="bib61">Wu et al., 2021</xref>) of the DE genes to identify antimicrobial pathway candidates in the three mutant macrophages. We found that defects in fatty acid uptake in <italic>Slc27a1</italic><sup>-/-</sup>-infected macrophages upregulated pro-inflammatory pathways involved in MAPK and ERK signaling and production of inflammatory cytokines (IFN‐γ, IL-6, IL-1α, β) (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). The pro-inflammatory signatures of the <italic>Slc27a1</italic><sup>-/-</sup> macrophages are consistent with previous observations that demonstrated that a deficiency in <italic>Slc27a1</italic><sup>-/-</sup> exacerbated macrophage activation in vitro and in vivo (<xref ref-type="bibr" rid="bib22">Johnson et al., 2016</xref>). SLC27A1 is a solute carrier family member transporter and <italic>Mtb</italic>-infected <italic>Slc27a1</italic><sup>-/-</sup> macrophages showed reduced expression of other solute carrier transporters (SLC) such as SLC27A4, GLUT1 (SLC2A1), and eight SLC amino acid transporters (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A, B and 2A</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Interestingly, <italic>Mtb</italic>-infected <italic>Slc27a1</italic><sup>-/-</sup> macrophage transcriptomes exhibited upregulation of macrophage scavenger receptors (MSR1) and the ATP binding cassette transporter ABCC1 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>), both of which can independently transport fatty acids into cells (<xref ref-type="bibr" rid="bib56">Vogel et al., 2022</xref>; <xref ref-type="bibr" rid="bib47">Raggers et al., 1999</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Dual RNA sequencing to identify host and bacterial determinants of <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>) restriction in macrophages with fatty acid import and metabolism knockout genes.</title><p>(<bold>A</bold>) Principal component analysis (PCA) of scramble or <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages transcriptomes infected with the <italic>Mtb</italic> smyc’::mCherry strain at a multiplicity of infection (MOI) of 0.5 4 days post infection. (<bold>B</bold>) Venn diagram of differentially expressed (DE) gene sets (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>) in <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2<sup>-</sup></italic><sup>/-</sup> mutant macrophages compared to scramble showing overlapping genes. DE genes cutoff; abs (log<sub>2</sub> fold change) &gt; 0.3, adjusted p-value&lt;0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig5-v1.tif"/></fig><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Pathway enrichment analysis of upregulated genes in <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>)-infected <italic>Plin2<sup>-</sup></italic><sup>/-</sup> and <italic>Slc27a1</italic><sup>-/-</sup> macrophages.</title><p>Tree plots of top 80 enriched gene ontology terms (biological process) in <italic>Mtb</italic>-infected <italic>Slc27a1</italic><sup>-/-</sup> (A) and <italic>Plin2</italic><sup>-/-</sup> (B) upregulated genes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Compensatory transcriptional responses in <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>)-infected <italic>Slc27a1</italic><sup>-/-</sup> macrophages.</title><p>(<bold>A, B</bold>) Violin plots showing expression (log2 normalized counts) of fatty acid (<bold>A</bold>) and amino acid transport genes (<bold>B</bold>) in <italic>Slc27a1</italic><sup>-/-</sup> mutant macrophages 4 days post infection (<xref ref-type="fig" rid="fig5">Figure 5</xref>). *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values  ± SD.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Tree plot of top 80 enriched gene ontology terms (biological process) in <italic>Slc27a1</italic><sup>-/-</sup> (A) and <italic>Plin2</italic><sup>-/-</sup> (B) macrophages downregulated genes.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Tree plot of top 80 enriched gene ontology terms (biological process) in <italic>Cpt2</italic><sup>-/-</sup> macrophages upregulated genes.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig6-figsupp3-v1.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title>qPCR analysis of IFN-β (A) and IL-1β (B) in <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages.</title><p>Macrophages were left uninfected or infected with the <italic>Mycobacterium tuberculosis (Mtb) Erdman</italic> strain at a multiplicity of infection (MOI) of 4. RNA was extracted for qPCR at 4 and 24 hours post infection. ***p&lt;0.001; ****p&lt;0.0001, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values  ± SD.</p><p><supplementary-material id="fig6s4sdata1"><label>Figure 6—figure supplement 4—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102980-fig6-figsupp4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig6-figsupp4-v1.tif"/></fig></fig-group><p>Meanwhile, <italic>Mtb</italic> infection of <italic>Plin2</italic><sup>-/-</sup> macrophages led to upregulation in pathways involved in ribosomal biology, MHC class 1 antigen presentation, canonical glycolysis, ATP metabolic processes, and type 1 interferon responses (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). In the downregulated <italic>Plin2</italic><sup>-/-</sup> DE gene set, enriched pathways included those involved in the production of pro-inflammatory cytokines; IL-6 and 8, IFN‐γ and IL-1 (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Oxidative phosphorylation and processes involved in the respiratory chain electron transport were also significantly enriched in <italic>Plin2</italic><sup>-/-</sup> downregulated genes. This suggests that <italic>Mtb</italic>-infected <italic>Plin2</italic><sup>-/-</sup> macrophages increase glycolytic flux and decrease mitochondrial activities, which is consistent with our metabolic flux analysis data (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Unlike <italic>Slc27a1</italic><sup>-/-</sup> macrophages, <italic>Plin2</italic><sup>-/-</sup> macrophages are, however, broadly anti-inflammatory as most pro-inflammatory genes were downregulated upon <italic>Mtb</italic> infection.</p><p>Further downstream in the lipid processing steps, inhibition of fatty acid oxidation in <italic>Cpt2</italic><sup>-/-</sup> macrophages upregulated pathways involved in MHC class 1 antigen presentation, response to IFN‐γ and IL-1 and T-cell-mediated immunity (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). There was a limited overlap in enriched pathways in the upregulated genes between <italic>Mtb</italic>-infected <italic>Cpt2</italic><sup>-/-</sup> and <italic>Slc27a1</italic><sup>-/-</sup> macrophages such as those involved in the cellular responses to IL-1 and IFN‐γ. However, many pathways over-represented in <italic>Cpt2</italic><sup>-/-</sup> macrophages were common to <italic>Plin2</italic><sup>-/-</sup> macrophages (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Similarly, both <italic>Mtb</italic>-infected <italic>Plin2</italic><sup>-/-</sup> <italic>and Cpt2</italic><sup>-/-</sup> macrophages were downregulated in the expression of genes involved in oxidative phosphorylation (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). We confirmed expression levels of a selected gene by qPCR analysis of IL-1β and the type 1 interferon (IFN-β) response during the early time points of infection. Indeed, 4 hours post infection, IL-1β and IFN-β were both upregulated in <italic>Slc27a1</italic><sup>-/-</sup> macrophages compared to scrambled controls consistent with their pro-inflammatory phenotype (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4A and B</xref>). On the contrary, <italic>Plin2</italic><sup>-/-</sup> macrophages downregulated IL-1β (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4B</xref>). These data indicate that macrophages respond quite divergently to the deletion of the different steps in fatty acid uptake, which implies that the intracellular pressures to which <italic>Mtb</italic> is exposed may also differ.</p></sec><sec id="s2-6"><title>Oxidative stress and nutrient limitation are major stresses experienced by <italic>Mtb</italic> in <italic>Plin2</italic><sup>-/-</sup> and <italic>Cpt2</italic><sup>-/-</sup> macrophages</title><p>We also analyzed transcriptomes from intracellular <italic>Mtb</italic> from scrambled controls, <italic>Slc27a1</italic><sup>-/-</sup>, <italic>Cpt2<sup>-/-</sup></italic>, and <italic>Plin2</italic><sup>-/-</sup> macrophages in parallel with host transcriptomes in <xref ref-type="fig" rid="fig5">Figure 5A</xref>. Using an adjusted p-value of &lt;0.1 and an absolute log<sub>2</sub> fold change &gt;1.4, 0 genes were DE in <italic>Slc27a1</italic><sup>-/-</sup> macrophages, 105 <italic>Mtb</italic> genes were DE in <italic>Plin2</italic><sup>-/-</sup> macrophages (69 up, 36 down), and 10 genes were DE in <italic>Cpt2</italic><sup>-/-</sup> macrophages (3 up, 7 down) (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Despite being restrictive to <italic>Mtb</italic> growth (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) and appearing more pro-inflammatory (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), <italic>Slc27a1</italic><sup>-/-</sup> macrophages did not elicit a detectable shift in the transcriptional response in <italic>Mtb</italic> compared to control host cells. We speculate that pro-inflammatory responses in <italic>Slc27a1</italic><sup>-/-</sup> macrophages could be enough to restrict the growth of bacteria, but the resulting compensatory responses as evidenced by the upregulation of macrophage scavenger receptors (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>) alleviate some of the stresses that a lack of fatty acid import could be duly exerting on the bacteria. <italic>Plin2</italic><sup>-/-</sup> macrophages appeared to elicit the strongest transcriptional response from <italic>Mtb,</italic> which is consistent with our CFU data (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) as <italic>Plin2</italic><sup>-/-</sup> macrophages exhibited the strongest growth restriction. Among the DE genes in <italic>Mtb</italic> from <italic>Plin2</italic><sup>-/-</sup> macrophages (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>), a significant number of upregulated genes are involved in nutrient assimilation (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). <italic>Mtb</italic> in <italic>Plin2</italic><sup>-/-</sup> macrophages upregulated CobU (Rv0254c), which is predicted to be involved in the bacteria’s cobalamin (vitamin B<sub>12</sub>) biosynthesis. Vitamin B<sub>12</sub> is an important cofactor for the activity of <italic>Mtb</italic> genes required for cholesterol and fatty acid utilization (<xref ref-type="bibr" rid="bib6">Campos-Pardos et al., 2024</xref>; <xref ref-type="bibr" rid="bib49">Savvi et al., 2008</xref>). Genes involved in de novo long-chain fatty acid synthesis (AccE5, Rv281) (<xref ref-type="bibr" rid="bib2">Bazet Lyonnet et al., 2014</xref>), cholesterol breakdown (HsaD, Rv3569c) (<xref ref-type="bibr" rid="bib28">Lack et al., 2010</xref>), β-oxidation of fatty acids (EchA18, Rv3373; FadE22, Rv3061c) (<xref ref-type="bibr" rid="bib50">Schnappinger et al., 2003</xref>), purine salvage (Apt, Rv2584c) (<xref ref-type="bibr" rid="bib57">Warner et al., 2014</xref>), and tryptophan metabolism (<xref ref-type="bibr" rid="bib33">Lott, 2020</xref>) were also upregulated in <italic>Mtb</italic> from <italic>Plin2</italic><sup>-/-</sup> macrophages (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). This metabolic realignment response is seen most frequently under nutrient-limiting conditions (<xref ref-type="bibr" rid="bib21">Huang et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Pisu et al., 2020</xref>; <xref ref-type="bibr" rid="bib55">Theriault et al., 2022</xref>). <italic>Mtb</italic> in <italic>Plin2</italic><sup>-/-</sup> macrophages also appears to experience a significant level of other cellular stresses as genes involved in DNA synthesis and repair, general response to oxidative stress and pH survival in the phagosome (DnaN, Rv0002; RecF, Rv0003; DinF, Rv2836c; Rv3242c, Rv1264) were upregulated (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Among the downregulated genes in <italic>Mtb</italic> in <italic>Plin2</italic><sup>-/-</sup> macrophages, FurA (Rv1909c), a KatG repressor was the most significant (<xref ref-type="fig" rid="fig7">Figure 7B</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). FurA downregulation derepresses the catalase peroxidase, KatG, which promotes <italic>Mtb</italic> survival in oxidative stress conditions (<xref ref-type="bibr" rid="bib62">Zahrt et al., 2001</xref>). These data suggest that <italic>Plin2<sup>-</sup></italic><sup>/-</sup> macrophages could be, in part, restricting <italic>Mtb</italic> growth by increasing the production of ROS. The data also suggest that, contrary to a previous report (<xref ref-type="bibr" rid="bib27">Knight et al., 2018</xref>), blocking lipid droplet formation in host macrophages does place increased nutritional and oxidative stress on intracellular <italic>Mtb</italic>.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Nutritional and oxidative stress define the core transcriptome response of <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>) inside <italic>Plin2</italic><sup>-/-</sup> macrophages.</title><p>Heatmaps of nutritional (<bold>A</bold>) and oxidative stress (<bold>B</bold>) differentially expressed (DE) genes in <italic>Plin2</italic><sup>-/-</sup> macrophages. Arrows show genes that are also DE in <italic>Cpt2</italic><sup>-/-</sup> macrophages in a similar trend (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Total cellular reactive oxygen species (ROS) in <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages.</title><p>(<bold>A, B</bold>) Scramble or <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages were left uninfected (<bold>A</bold>) or infected (<bold>B</bold>) with the <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>) Erdman strain at a multiplicity of infection (MOI) of 1 for 24 hours. Live cells were stained with the Invitrogen CellROX Deep Red dye and imaged using a confocal microscope. Mean fluorescence intensities (MFI) per individual cell were quantified using ImageJ in at least 100 cells for every mutant across three biological replicates. **p&lt;0.01; ****p&lt;0.0001, one-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values  ± SD.</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102980-fig7-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig7-figsupp1-v1.tif"/></fig></fig-group><p><italic>Cpt2</italic><sup>-/-</sup> macrophages elicited a modest shift in transcriptional response from <italic>Mtb</italic>, and the majority of the DE genes (8 out of 10) were also DE in <italic>Plin2</italic><sup>-/-</sup> macrophages (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). This is in agreement with the host transcription response as <italic>Cpt2</italic><sup>-/-</sup> and <italic>Plin2</italic><sup>-/-</sup> macrophages share similar candidate antibacterial responses (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>, <xref ref-type="fig" rid="fig6">Figure 6</xref>, <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>). In common with the <italic>Mtb</italic> transcriptome response in <italic>Plin2</italic><sup>-/-</sup> macrophages, upregulated genes in <italic>Mtb</italic> isolated from <italic>Cpt2</italic><sup>-/-</sup> macrophages included those involved in response to oxidative stress (DinF, Rv2836c) (<xref ref-type="fig" rid="fig7">Figure 7B</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). To substantiate some of these pathways, we assessed the levels of total cellular ROS in <italic>Slc27a1</italic><sup>-/-</sup>, <italic>Plin2</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> macrophages in both <italic>Mtb</italic>-infected and uninfected conditions by staining the cells with the Invitrogen CellROX dye and confocal microscopy analysis of live stained cells. In both infected and uninfected conditions, all the three mutants displayed significantly elevated total cellular ROS compared to scramble controls (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A and B</xref>).</p></sec><sec id="s2-7"><title>Inhibitors of lipid metabolism block intracellular growth of <italic>Mtb</italic> in macrophages but not in broth culture</title><p>We next examined if pharmacological inhibitors would phenocopy the growth inhibition phenotypes we observed with specific gene deletions. Compounds that modulate lipid homeostasis are currently being investigated for HDT against TB, which is an area of considerable interest (<xref ref-type="bibr" rid="bib25">Kim et al., 2020</xref>). Such compounds include metformin, a widely used antidiabetic drug that activates AMPK, inhibits fatty acid synthesis, and promotes β-oxidation of fatty acids (<xref ref-type="bibr" rid="bib14">Fullerton et al., 2013</xref>; <xref ref-type="bibr" rid="bib54">Singhal et al., 2014</xref>). Chemical inhibition of fatty acid β-oxidation is already known to promote macrophage control of <italic>Mtb</italic> (<xref ref-type="bibr" rid="bib7">Chandra et al., 2020</xref>; <xref ref-type="bibr" rid="bib21">Huang et al., 2018</xref>). We targeted macrophage lipid homeostasis with trimetazidine (TMZ), an inhibitor of β-oxidation of fatty acids, metformin, and an SLC27A1 inhibitor, FATP1 In (<xref ref-type="bibr" rid="bib34">Matsufuji et al., 2013</xref>). We assessed the impact of these compounds on extracellular <italic>Mtb</italic> cultured in broth over 9 days in the presence of the inhibitors (DMSO, TMZ; 500 nM, metformin; 2 mM, FATP1 In; 10 μM, rifampicin; 0.5 μg/ml). None of the three lipid metabolism inhibitors had a measurable effect on <italic>Mtb</italic> growth in liquid culture media compared to DMSO controls (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). Treatment with rifampicin completely blocked bacterial growth under the same conditions (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). We next infected scrambled sgRNA control macrophages with <italic>Mtb</italic> at MOI 0.5. Inhibitors were added to infected macrophages 3 hours post infection, and bacterial CFUs were enumerated 4 days post treatment. Consistent with previous observations (<xref ref-type="bibr" rid="bib7">Chandra et al., 2020</xref>; <xref ref-type="bibr" rid="bib54">Singhal et al., 2014</xref>), TMZ and metformin significantly reduced bacterial loads in macrophages compared to DMSO controls (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). Similarly, FATP1 In also impacted the intracellular growth of <italic>Mtb</italic> (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). The results provide independent data that both genetic and chemical modulation of fatty acid metabolism at different steps in the process negatively impact intracellular growth of <italic>Mtb</italic>.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Inhibitors of fatty acid transport and metabolism block intracellular growth of <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>) in macrophages.</title><p>(A) Growth of <italic>Mtb</italic> in liquid broth in the absence of drug (DMSO) or presence of metformin, SLC27A1 inhibitor (FATP1 In, 10 μM) and the β-oxidation of fatty acid inhibitor, trimetazidine (TMZ, 500 nM). <italic>Mtb</italic> Erdman was grown to log phase and diluted to OD<sub>600</sub> 0.01 in 7H9 media in the presence of the above inhibitors. Growth kinetics were monitored by OD<sub>600</sub> measurements using a plate reader. Rifampicin (RIF) at 0.5 μg/ml was used as a total killing control. (B) Scramble macrophages were infected with <italic>Mtb</italic> Erdman at MOI 0.5. Inhibitors were added 3 hours post infection following which CFUs were plated 4 days post infection. n = 5 biological replicates; **p&lt;0.01; ****p&lt;0.0001, one-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig8">Figure 8A and B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102980-fig8-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102980-fig8-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>It is clearly established that host-derived fatty acids and cholesterol are important carbon sources for <italic>Mtb</italic> (<xref ref-type="bibr" rid="bib59">Wilburn et al., 2018</xref>). However, the relationship between <italic>Mtb</italic> and the infected host cell lipid metabolism remains a subject of conjecture. In this report, we characterized the role of macrophage lipid metabolism on the intracellular growth of <italic>Mtb</italic> by a targeted CRISPR-mediated knockout of host genes involved in fatty acid import, sequestration, and catabolism. Macrophage fatty acid uptake is mediated by the scavenger receptor CD36 and specialized long-chain fatty acid transporters, SLC27A1 and SLC27A4 (<xref ref-type="bibr" rid="bib13">Deng et al., 2023</xref>). Earlier studies reported that a deficiency of CD36 enhances macrophage control of <italic>Mtb,</italic> albeit to a modest degree (<xref ref-type="bibr" rid="bib20">Hawkes et al., 2010</xref>). Work from <xref ref-type="bibr" rid="bib20">Hawkes et al., 2010</xref> indicated that the antimicrobial effectors in CD36-deficient macrophages were not due to bacterial uptake deficiencies, differences in the rate of <italic>Mtb-</italic>induced host cell death, and production of ROS or pro-inflammatory cytokines (<xref ref-type="bibr" rid="bib20">Hawkes et al., 2010</xref>). We similarly observed a moderate <italic>Mtb</italic> growth restriction phenotype in our CRISPR-generated <italic>Cd36</italic><sup>-/-</sup> macrophages. However, a strong growth restriction of <italic>Mtb</italic> was observed when we knocked out the long-chain fatty acid transporter, SLC27A1. <italic>Slc27a1</italic><sup>-/-</sup> macrophages displayed altered metabolism characterized by the stabilization of HIF1α, activated AMPK, increased glycolysis, and reduced mitochondrial functions. Given that both CD36 and SLC27A1 perform similar functions, it is expected that there should be some degree of compensation between the transporters when either of the genes are deleted. Indeed, we found out that SLC27A1 knockout resulted in the upregulation of other lipid import transporters (MSR1, ABCC1). This would be consistent with the moderate anti-<italic>Mtb</italic> phenotypes in <italic>Cd36</italic><sup>-/-</sup> macrophages that could easily be compensated by the presence of <italic>long-chain fatty acid transporters</italic> to alleviate the reduction in fatty acid supply experienced by intracellular <italic>Mtb</italic>. However, the <italic>Slc27a1</italic><sup>-/-</sup> macrophage phenotype appears to be more severe on <italic>Mtb</italic> and could be exacerbated by an elevated pro-inflammatory response as has been reported previously both in vitro and in vivo (<xref ref-type="bibr" rid="bib22">Johnson et al., 2016</xref>).</p><p>After uptake into the cells, most fatty acids either undergo β-oxidation in the mitochondria to provide energy or are esterified with glycerol phosphate to form triacylglycerols that may be incorporated into lipid droplets in the endoplasmic reticulum (<xref ref-type="bibr" rid="bib13">Deng et al., 2023</xref>). Over the last two decades, it has been believed that lipid droplets are a nutrient source for <italic>Mtb</italic> in macrophages (<xref ref-type="bibr" rid="bib48">Russell et al., 2009</xref>; <xref ref-type="bibr" rid="bib12">Daniel et al., 2011</xref>; <xref ref-type="bibr" rid="bib43">Peyron et al., 2008</xref>; <xref ref-type="bibr" rid="bib53">Singh et al., 2012</xref>). However, recent work indicates lipid droplets may serve as centers for the production of pro-inflammatory markers and antimicrobial peptides (<xref ref-type="bibr" rid="bib27">Knight et al., 2018</xref>; <xref ref-type="bibr" rid="bib4">Bosch et al., 2020</xref>). It has also been reported that bone marrow macrophages derived from <italic>Plin2</italic><sup>-/-</sup> mice did not have defects in the formation of lipid droplets and supported robust intracellular <italic>Mtb</italic> replication (<xref ref-type="bibr" rid="bib27">Knight et al., 2018</xref>). However, our mutant macrophages with myeloid-specific knockout of PLIN2 are unable to form lipid droplets and are defective in supporting the growth of <italic>Mtb</italic>. The discrepancies with previous observations (<xref ref-type="bibr" rid="bib27">Knight et al., 2018</xref>) could be a consequence of compensatory responses to PLIN2 knockout in whole mice, which when performed at embryonic level would allow for sufficient time for the cells to recover by upregulating related PLIN isoforms. In fact, <italic>Plin2</italic><sup>-/-</sup> macrophages displayed the strongest anti-<italic>Mtb</italic> phenotypes amongst our mutants exhibiting activated AMPK, increased glycolysis and autophagy, and impaired mitochondrial functions. <italic>Mtb</italic> isolated from <italic>Plin2</italic><sup>-/-</sup> macrophages displayed signatures of severe nutrient limitation and oxidative stress damage.</p><p>It has also been previously reported that chemical, genetic, or miR33-mediated blockade of fatty acid β-oxidation in macrophages induces lipid droplet formation (<xref ref-type="bibr" rid="bib7">Chandra et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">Ouimet et al., 2016</xref>) but that this enhanced lipid droplet formation does not correlate with improved intracellular <italic>Mtb</italic> growth (<xref ref-type="bibr" rid="bib7">Chandra et al., 2020</xref>). We observed a similar phenotype as <italic>Cpt2<sup>-</sup></italic><sup>/-</sup> macrophages that generated larger and more abundant lipid droplets than scrambled control macrophages were still restrictive to <italic>Mtb</italic> growth. This implies that the presence or absence of lipid droplets does not in itself indicate whether a macrophage will support or restrict <italic>Mtb</italic> growth, and that the antimicrobial environment extends beyond simple nutrient availability.</p><p>In summary, our study shows that blocking macrophage’s ability to import, sequester, or catabolize fatty acids chemically or by genetic knockout impairs <italic>Mtb</italic> intracellular growth. There are shared features between potential antimicrobial effectors in macrophages that lack the ability to import (<italic>Slc27a1</italic><sup>-/-</sup>) or metabolize fatty acids (<italic>Plin2</italic><sup>-/-</sup>, <italic>Cpt2</italic><sup>-/-</sup>) such as increased glycolysis, stabilized HIF1α, activated AMPK, enhanced autophagy, and production of ROS. However, there are also intriguing points of divergence as <italic>Slc27a1</italic><sup>-/-</sup> macrophages are more pro-inflammatory while <italic>Plin2</italic><sup>-/-</sup> macrophages appear to be broadly anti-inflammatory. The routes to <italic>Mtb</italic> growth restriction in these mutant macrophages are clearly more complex than the bacteria’s inability to acquire nutrients. The data further emphasizes that targeting fatty acid homeostasis in macrophages at different steps in the process (uptake, storage, and catabolism) is worthy of exploring in the development of new therapeutics against TB.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><p>All materials and methods are as described (<xref ref-type="bibr" rid="bib52">Simwela et al., 2024</xref>) unless otherwise specified.</p><sec id="s4-1"><title>Flow cytometry and western blot analysis</title><p>Generation of CRISPR mutant Hoxb8 macrophages was carried out as described previously (<xref ref-type="bibr" rid="bib52">Simwela et al., 2024</xref>). Antibodies used for both western blot and flow cytometry were as follows: rat anti-mouse CD36:Alexa Fluor647 (Bio-Rad, 10 μl/million cells), rabbit anti-PLIN2 (Proteintech, 1:1000), rabbit anti-SLC27A1 (Affinity Biosciences, 1:1000), rabbit anti-CPT1A antibody (Proteintech, 1:1000), rabbit anti-CPT2 antibody (Proteintech, 1:1000), rabbit anti-HIF1α antibody (Proteintech, 1:1000), rabbit anti-AMPKα (1:1000, Cell Signalling Technology), rabbit anti-Phospho-AMPKα (1:500, Cell Signalling Technology), rabbit anti-LC3B (1:1000, Cell Signalling Technology), and rabbit anti-β-actin (1:1000, Cell Signalling Technology). For western blots, secondary antibodies used were anti-rabbit/mouse StarBright Blue 700 (1:2500, Bio-Rad). Blots were developed and imaged as described previously (<xref ref-type="bibr" rid="bib52">Simwela et al., 2024</xref>).</p></sec><sec id="s4-2"><title>Staining for cellular lipid droplets</title><p>Macrophages monolayers in Ibidi eight-well chambers were supplemented with exogenous 400 μM oleate for 24 hours to induce the formation of lipid droplets (<xref ref-type="bibr" rid="bib32">Listenberger and Brown, 2007</xref>). Cells were then fixed in 4% paraformaldehyde and stained with BODIPY 493/503 (Invitrogen, 1 μg/ml) in 150 mM sodium chloride. Stained cells were mounted with media containing DAPI and imaged using a Leica SP5 confocal microscope.</p></sec><sec id="s4-3"><title>Seahorse XF palmitate oxidation stress test</title><p>A modified Seahorse mitochondrial stress test was used to measure macrophage’s ability to oxidize palmitate in substrate-limiting conditions. Two days before the assay, 1 × 10<sup>5</sup> cells were plated in Seahorse cell culture mini plates. One day before the assay, macrophage media was replaced with the Seahorse substrate-limited growth media (DMEM without pyruvate supplemented with 0.5 mM glucose, 1 mM glutamine, 1% FBS, and 0.5 mM L-carnitine). On the day of the assay, substrate-limited media was replaced with assay media (DMEM without pyruvate supplemented with 2 mM glucose and 0.5 mM L-carnitine). In selected treatment conditions, cells were either supplied with BSA, BSA palmitate, or BSA palmitate plus etomoxir (4 μM). OCRs were measured using the Mito Stress Test assay conditions as described previously (<xref ref-type="bibr" rid="bib52">Simwela et al., 2024</xref>).</p></sec><sec id="s4-4"><title>Rescue of the <italic>Mtb</italic> Δicl1 mutant in oleate supplemented media</title><p>The <italic>Mtb</italic> H37Rv Δ<italic>icl1</italic> mutant expressing mCherry (<xref ref-type="bibr" rid="bib30">Lee et al., 2013</xref>) was used for the rescue experiments. The strain was maintained in 7H9 OADC broth as previously described (<xref ref-type="bibr" rid="bib52">Simwela et al., 2024</xref>) in the presence of kanamycin (25 μg/ml) and hygromycin (50 μg/ml). 24 hours before infection, macrophages were cultured in normal macrophage media or media supplemented with 400 μM oleate. Cells were then infected with the <italic>Mtb</italic> Δ<italic>icl1</italic> mutant at MOI 5. The bacterial mCherry signal was measured on day 0 and day 5 post infection on an Envision plate reader (PerkinElmer). Oleate was maintained throughout the experiment in the rescue assay conditions.</p></sec><sec id="s4-5"><title>Measurement of total cellular ROS</title><p>Uninfected or <italic>Mtb</italic>-infected macrophages monolayers in Ibidi eight-well chambers were stained with the CellROX Deep Red dye (Invitrogen) as per the manufacturer’s staining protocol. Live stained cells were imaged on a Leica SP5 confocal microscope. Z-stacks were reconstructed in ImageJ from which mean fluorescence intensities (MFIs) for individual cells were obtained.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Visualization</p></fn><fn fn-type="con" id="con3"><p>Resources, Visualization</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All of our protocols were reviewed and approved by Institutional Animal Care and User Committee of Cornell University, protocol # 2011-0086.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>sgRNAs primers and ICE scores for lipid import and metabolism gene targets in this study.</title></caption><media xlink:href="elife-102980-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Differentially expressed genes in <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> <italic>Mtb</italic>-infected macrophages.</title></caption><media xlink:href="elife-102980-supp2-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Enriched GO terms in upregulated and downregulated genes in <italic>Plin2</italic><sup>-/-</sup>, <italic>Slc27a1</italic><sup>-/-</sup>, and <italic>Cpt2</italic><sup>-/-</sup> <italic>Mtb-</italic>infected macrophages.</title></caption><media xlink:href="elife-102980-supp3-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title><italic>Mtb</italic> differentially expressed genes in <italic>Plin2</italic><sup>-/-</sup> and <italic>Cpt2</italic><sup>-/-</sup> infected macrophages.</title></caption><media xlink:href="elife-102980-supp4-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-102980-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The RNA-seq data from the dual RNA-seq analysis of infected mouse macrophages, which includes both macrophage and Mtb reads, are available in GEO (GSE270571).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Simwela</surname><given-names>NV</given-names></name><name><surname>Jaecklein</surname><given-names>E</given-names></name><name><surname>Sassetti</surname><given-names>CM</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Impaired fatty acid import and metabolism in macrophages restricts intracellular growth of <italic>Mycobacterium tuberculosis</italic></data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270571">GSE270571</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Dr. Jen K Grenier and Ann E Tate from the Cornell BRC Transcriptional Regulation and Expression Facility for their help with the development of dual RNA-Seq protocols. This work was supported by grants from the National Institutes of Health (AI155319, AI162598, and OD032135), Bill and Melinda Gates Foundation, and the Mueller Health Foundation to DGR. EJ was supported by T32AI007349.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>PE</given-names></name><name><surname>Silva</surname><given-names>AR</given-names></name><name><surname>Maya-Monteiro</surname><given-names>CM</given-names></name><name><surname>Töröcsik</surname><given-names>D</given-names></name><name><surname>D’Avila</surname><given-names>H</given-names></name><name><surname>Dezsö</surname><given-names>B</given-names></name><name><surname>Magalhães</surname><given-names>KG</given-names></name><name><surname>Castro-Faria-Neto</surname><given-names>HC</given-names></name><name><surname>Nagy</surname><given-names>L</given-names></name><name><surname>Bozza</surname><given-names>PT</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title><italic>Mycobacterium bovis</italic> bacillus Calmette-Guérin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: functions in inflammation, lipid metabolism, and pathogenesis</article-title><source>Journal of Immunology</source><volume>183</volume><fpage>1337</fpage><lpage>1345</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0900365</pub-id><pub-id pub-id-type="pmid">19561094</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazet Lyonnet</surname><given-names>B</given-names></name><name><surname>Diacovich</surname><given-names>L</given-names></name><name><surname>Cabruja</surname><given-names>M</given-names></name><name><surname>Bardou</surname><given-names>F</given-names></name><name><surname>Quémard</surname><given-names>A</given-names></name><name><surname>Gago</surname><given-names>G</given-names></name><name><surname>Gramajo</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pleiotropic effect of AccD5 and AccE5 depletion in acyl-coenzyme A carboxylase activity and in lipid biosynthesis in mycobacteria</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e99853</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0099853</pub-id><pub-id pub-id-type="pmid">24950047</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belton</surname><given-names>M</given-names></name><name><surname>Brilha</surname><given-names>S</given-names></name><name><surname>Manavaki</surname><given-names>R</given-names></name><name><surname>Mauri</surname><given-names>F</given-names></name><name><surname>Nijran</surname><given-names>K</given-names></name><name><surname>Hong</surname><given-names>YT</given-names></name><name><surname>Patel</surname><given-names>NH</given-names></name><name><surname>Dembek</surname><given-names>M</given-names></name><name><surname>Tezera</surname><given-names>L</given-names></name><name><surname>Green</surname><given-names>J</given-names></name><name><surname>Moores</surname><given-names>R</given-names></name><name><surname>Aigbirhio</surname><given-names>F</given-names></name><name><surname>Al-Nahhas</surname><given-names>A</given-names></name><name><surname>Fryer</surname><given-names>TD</given-names></name><name><surname>Elkington</surname><given-names>PT</given-names></name><name><surname>Friedland</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hypoxia and tissue destruction in pulmonary TB</article-title><source>Thorax</source><volume>71</volume><fpage>1145</fpage><lpage>1153</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2015-207402</pub-id><pub-id pub-id-type="pmid">27245780</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch</surname><given-names>M</given-names></name><name><surname>Sánchez-Álvarez</surname><given-names>M</given-names></name><name><surname>Fajardo</surname><given-names>A</given-names></name><name><surname>Kapetanovic</surname><given-names>R</given-names></name><name><surname>Steiner</surname><given-names>B</given-names></name><name><surname>Dutra</surname><given-names>F</given-names></name><name><surname>Moreira</surname><given-names>L</given-names></name><name><surname>López</surname><given-names>JA</given-names></name><name><surname>Campo</surname><given-names>R</given-names></name><name><surname>Marí</surname><given-names>M</given-names></name><name><surname>Morales-Paytuví</surname><given-names>F</given-names></name><name><surname>Tort</surname><given-names>O</given-names></name><name><surname>Gubern</surname><given-names>A</given-names></name><name><surname>Templin</surname><given-names>RM</given-names></name><name><surname>Curson</surname><given-names>JEB</given-names></name><name><surname>Martel</surname><given-names>N</given-names></name><name><surname>Català</surname><given-names>C</given-names></name><name><surname>Lozano</surname><given-names>F</given-names></name><name><surname>Tebar</surname><given-names>F</given-names></name><name><surname>Enrich</surname><given-names>C</given-names></name><name><surname>Vázquez</surname><given-names>J</given-names></name><name><surname>Del Pozo</surname><given-names>MA</given-names></name><name><surname>Sweet</surname><given-names>MJ</given-names></name><name><surname>Bozza</surname><given-names>PT</given-names></name><name><surname>Gross</surname><given-names>SP</given-names></name><name><surname>Parton</surname><given-names>RG</given-names></name><name><surname>Pol</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense</article-title><source>Science</source><volume>370</volume><elocation-id>eaay8085</elocation-id><pub-id pub-id-type="doi">10.1126/science.aay8085</pub-id><pub-id pub-id-type="pmid">33060333</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brzostek</surname><given-names>A</given-names></name><name><surname>Pawelczyk</surname><given-names>J</given-names></name><name><surname>Rumijowska-Galewicz</surname><given-names>A</given-names></name><name><surname>Dziadek</surname><given-names>B</given-names></name><name><surname>Dziadek</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title><italic>Mycobacterium tuberculosis</italic> is able to accumulate and utilize cholesterol</article-title><source>Journal of Bacteriology</source><volume>191</volume><fpage>6584</fpage><lpage>6591</lpage><pub-id pub-id-type="doi">10.1128/JB.00488-09</pub-id><pub-id pub-id-type="pmid">19717592</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campos-Pardos</surname><given-names>E</given-names></name><name><surname>Uranga</surname><given-names>S</given-names></name><name><surname>Picó</surname><given-names>A</given-names></name><name><surname>Gómez</surname><given-names>AB</given-names></name><name><surname>Gonzalo-Asensio</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Dependency on host vitamin B12 has shaped <italic>Mycobacterium tuberculosis</italic> Complex evolution</article-title><source>Nature Communications</source><volume>15</volume><elocation-id>2161</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-024-46449-8</pub-id><pub-id pub-id-type="pmid">38461302</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>P</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Zimmerman</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Köster</surname><given-names>S</given-names></name><name><surname>Ouimet</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Moore</surname><given-names>KJ</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name><name><surname>Schilling</surname><given-names>JD</given-names></name><name><surname>Philips</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Inhibition of fatty acid oxidation promotes macrophage control of <italic>Mycobacterium tuberculosis</italic></article-title><source>mBio</source><volume>11</volume><elocation-id>e01139-20</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01139-20</pub-id><pub-id pub-id-type="pmid">32636249</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>SB</given-names></name><name><surname>Gern</surname><given-names>BH</given-names></name><name><surname>Delahaye</surname><given-names>JL</given-names></name><name><surname>Adams</surname><given-names>KN</given-names></name><name><surname>Plumlee</surname><given-names>CR</given-names></name><name><surname>Winkler</surname><given-names>JK</given-names></name><name><surname>Sherman</surname><given-names>DR</given-names></name><name><surname>Gerner</surname><given-names>MY</given-names></name><name><surname>Urdahl</surname><given-names>KB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Alveolar macrophages provide an early <italic>Mycobacterium tuberculosis</italic> niche and initiate dissemination</article-title><source>Cell Host &amp; Microbe</source><volume>24</volume><fpage>439</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2018.08.001</pub-id><pub-id pub-id-type="pmid">30146391</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conant</surname><given-names>D</given-names></name><name><surname>Hsiau</surname><given-names>T</given-names></name><name><surname>Rossi</surname><given-names>N</given-names></name><name><surname>Oki</surname><given-names>J</given-names></name><name><surname>Maures</surname><given-names>T</given-names></name><name><surname>Waite</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Joshi</surname><given-names>S</given-names></name><name><surname>Kelso</surname><given-names>R</given-names></name><name><surname>Holden</surname><given-names>K</given-names></name><name><surname>Enzmann</surname><given-names>BL</given-names></name><name><surname>Stoner</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Inference of CRISPR edits from sanger trace data</article-title><source>The CRISPR Journal</source><volume>5</volume><fpage>123</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1089/crispr.2021.0113</pub-id><pub-id pub-id-type="pmid">35119294</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courtnay</surname><given-names>R</given-names></name><name><surname>Ngo</surname><given-names>DC</given-names></name><name><surname>Malik</surname><given-names>N</given-names></name><name><surname>Ververis</surname><given-names>K</given-names></name><name><surname>Tortorella</surname><given-names>SM</given-names></name><name><surname>Karagiannis</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K</article-title><source>Molecular Biology Reports</source><volume>42</volume><fpage>841</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1007/s11033-015-3858-x</pub-id><pub-id pub-id-type="pmid">25689954</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cumming</surname><given-names>BM</given-names></name><name><surname>Addicott</surname><given-names>KW</given-names></name><name><surname>Adamson</surname><given-names>JH</given-names></name><name><surname>Steyn</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title><italic>Mycobacterium tuberculosis</italic> induces decelerated bioenergetic metabolism in human macrophages</article-title><source>eLife</source><volume>7</volume><elocation-id>e39169</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.39169</pub-id><pub-id pub-id-type="pmid">30444490</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniel</surname><given-names>J</given-names></name><name><surname>Maamar</surname><given-names>H</given-names></name><name><surname>Deb</surname><given-names>C</given-names></name><name><surname>Sirakova</surname><given-names>TD</given-names></name><name><surname>Kolattukudy</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title><italic>Mycobacterium tuberculosis</italic> uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages</article-title><source>PLOS Pathogens</source><volume>7</volume><elocation-id>e1002093</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002093</pub-id><pub-id pub-id-type="pmid">21731490</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>L</given-names></name><name><surname>Kersten</surname><given-names>S</given-names></name><name><surname>Stienstra</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Triacylglycerol uptake and handling by macrophages: From fatty acids to lipoproteins</article-title><source>Progress in Lipid Research</source><volume>92</volume><elocation-id>101250</elocation-id><pub-id pub-id-type="doi">10.1016/j.plipres.2023.101250</pub-id><pub-id pub-id-type="pmid">37619883</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fullerton</surname><given-names>MD</given-names></name><name><surname>Galic</surname><given-names>S</given-names></name><name><surname>Marcinko</surname><given-names>K</given-names></name><name><surname>Sikkema</surname><given-names>S</given-names></name><name><surname>Pulinilkunnil</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>Z-P</given-names></name><name><surname>O’Neill</surname><given-names>HM</given-names></name><name><surname>Ford</surname><given-names>RJ</given-names></name><name><surname>Palanivel</surname><given-names>R</given-names></name><name><surname>O’Brien</surname><given-names>M</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name><name><surname>Macaulay</surname><given-names>SL</given-names></name><name><surname>Schertzer</surname><given-names>JD</given-names></name><name><surname>Dyck</surname><given-names>JRB</given-names></name><name><surname>van Denderen</surname><given-names>BJ</given-names></name><name><surname>Kemp</surname><given-names>BE</given-names></name><name><surname>Steinberg</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin</article-title><source>Nature Medicine</source><volume>19</volume><fpage>1649</fpage><lpage>1654</lpage><pub-id pub-id-type="doi">10.1038/nm.3372</pub-id><pub-id pub-id-type="pmid">24185692</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>D</given-names></name><name><surname>Shaw</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance</article-title><source>Molecular Cell</source><volume>66</volume><fpage>789</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.05.032</pub-id><pub-id pub-id-type="pmid">28622524</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gleeson</surname><given-names>LE</given-names></name><name><surname>Sheedy</surname><given-names>FJ</given-names></name><name><surname>Palsson-McDermott</surname><given-names>EM</given-names></name><name><surname>Triglia</surname><given-names>D</given-names></name><name><surname>O’Leary</surname><given-names>SM</given-names></name><name><surname>O’Sullivan</surname><given-names>MP</given-names></name><name><surname>O’Neill</surname><given-names>LAJ</given-names></name><name><surname>Keane</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cutting edge: <italic>Mycobacterium tuberculosis</italic> induces aerobic glycolysis in human alveolar macrophages that is required for control of intracellular bacillary replication</article-title><source>Journal of Immunology</source><volume>196</volume><fpage>2444</fpage><lpage>2449</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1501612</pub-id><pub-id pub-id-type="pmid">26873991</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>TA</given-names></name><name><surname>van de Langemheen</surname><given-names>H</given-names></name><name><surname>Muñoz-Elías</surname><given-names>EJ</given-names></name><name><surname>McKinney</surname><given-names>JD</given-names></name><name><surname>Sacchettini</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in <italic>Mycobacterium tuberculosis</italic></article-title><source>Molecular Microbiology</source><volume>61</volume><fpage>940</fpage><lpage>947</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05297.x</pub-id><pub-id pub-id-type="pmid">16879647</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>JE</given-names></name><name><surname>Pandey</surname><given-names>AK</given-names></name><name><surname>Gilmore</surname><given-names>SA</given-names></name><name><surname>Mizrahi</surname><given-names>V</given-names></name><name><surname>McKinney</surname><given-names>JD</given-names></name><name><surname>Bertozzi</surname><given-names>CR</given-names></name><name><surname>Sassetti</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cholesterol catabolism by <italic>Mycobacterium tuberculosis</italic> requires transcriptional and metabolic adaptations</article-title><source>Chemistry &amp; Biology</source><volume>19</volume><fpage>218</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2011.12.016</pub-id><pub-id pub-id-type="pmid">22365605</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez</surname><given-names>MG</given-names></name><name><surname>Master</surname><given-names>SS</given-names></name><name><surname>Singh</surname><given-names>SB</given-names></name><name><surname>Taylor</surname><given-names>GA</given-names></name><name><surname>Colombo</surname><given-names>MI</given-names></name><name><surname>Deretic</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Autophagy is a defense mechanism inhibiting BCG and <italic>Mycobacterium tuberculosis</italic> survival in infected macrophages</article-title><source>Cell</source><volume>119</volume><fpage>753</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.11.038</pub-id><pub-id pub-id-type="pmid">15607973</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkes</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Crockett</surname><given-names>M</given-names></name><name><surname>Diassiti</surname><given-names>A</given-names></name><name><surname>Finney</surname><given-names>C</given-names></name><name><surname>Min-Oo</surname><given-names>G</given-names></name><name><surname>Liles</surname><given-names>WC</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Kain</surname><given-names>KC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>CD36 deficiency attenuates experimental mycobacterial infection</article-title><source>BMC Infectious Diseases</source><volume>10</volume><elocation-id>299</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-10-299</pub-id><pub-id pub-id-type="pmid">20950462</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Nazarova</surname><given-names>EV</given-names></name><name><surname>Tan</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Growth of <italic>Mycobacterium tuberculosis</italic> in vivo segregates with host macrophage metabolism and ontogeny</article-title><source>The Journal of Experimental Medicine</source><volume>215</volume><fpage>1135</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1084/jem.20172020</pub-id><pub-id pub-id-type="pmid">29500179</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>AR</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Cozzo</surname><given-names>AJ</given-names></name><name><surname>Freemerman</surname><given-names>AJ</given-names></name><name><surname>Huang</surname><given-names>MJ</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Sampey</surname><given-names>BP</given-names></name><name><surname>Milner</surname><given-names>JJ</given-names></name><name><surname>Beck</surname><given-names>MA</given-names></name><name><surname>Damania</surname><given-names>B</given-names></name><name><surname>Rashid</surname><given-names>N</given-names></name><name><surname>Galanko</surname><given-names>JA</given-names></name><name><surname>Lee</surname><given-names>DP</given-names></name><name><surname>Edin</surname><given-names>ML</given-names></name><name><surname>Zeldin</surname><given-names>DC</given-names></name><name><surname>Fueger</surname><given-names>PT</given-names></name><name><surname>Dietz</surname><given-names>B</given-names></name><name><surname>Stahl</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Makowski</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation</article-title><source>Molecular Metabolism</source><volume>5</volume><fpage>506</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2016.04.005</pub-id><pub-id pub-id-type="pmid">27408776</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M-J</given-names></name><name><surname>Wainwright</surname><given-names>HC</given-names></name><name><surname>Locketz</surname><given-names>M</given-names></name><name><surname>Bekker</surname><given-names>L-G</given-names></name><name><surname>Walther</surname><given-names>GB</given-names></name><name><surname>Dittrich</surname><given-names>C</given-names></name><name><surname>Visser</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Hsu</surname><given-names>F-F</given-names></name><name><surname>Wiehart</surname><given-names>U</given-names></name><name><surname>Tsenova</surname><given-names>L</given-names></name><name><surname>Kaplan</surname><given-names>G</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism</article-title><source>EMBO Molecular Medicine</source><volume>2</volume><fpage>258</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1002/emmm.201000079</pub-id><pub-id pub-id-type="pmid">20597103</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>HM</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Yang</surname><given-names>CS</given-names></name><name><surname>Kim</surname><given-names>TS</given-names></name><name><surname>Jung</surname><given-names>M</given-names></name><name><surname>Jin</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Jang</surname><given-names>J</given-names></name><name><surname>Oh</surname><given-names>GT</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Jo</surname><given-names>EK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>PPAR-α activation mediates innate host defense through induction of TFEB and lipid catabolism</article-title><source>Journal of Immunology</source><volume>198</volume><fpage>3283</fpage><lpage>3295</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601920</pub-id><pub-id pub-id-type="pmid">28275133</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>YR</given-names></name><name><surname>Yang</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Host-directed therapy in tuberculosis: targeting host metabolism</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>1790</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.01790</pub-id><pub-id pub-id-type="pmid">32903583</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiritsy</surname><given-names>MC</given-names></name><name><surname>McCann</surname><given-names>K</given-names></name><name><surname>Mott</surname><given-names>D</given-names></name><name><surname>Holland</surname><given-names>SM</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name><name><surname>Sassetti</surname><given-names>CM</given-names></name><name><surname>Olive</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mitochondrial respiration contributes to the interferon gamma response in antigen-presenting cells</article-title><source>eLife</source><volume>10</volume><elocation-id>e65109</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.65109</pub-id><pub-id pub-id-type="pmid">34726598</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>M</given-names></name><name><surname>Braverman</surname><given-names>J</given-names></name><name><surname>Asfaha</surname><given-names>K</given-names></name><name><surname>Gronert</surname><given-names>K</given-names></name><name><surname>Stanley</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Lipid droplet formation in <italic>Mycobacterium tuberculosis</italic> infected macrophages requires IFN-γ/HIF-1α signaling and supports host defense</article-title><source>PLOS Pathogens</source><volume>14</volume><elocation-id>e1006874</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006874</pub-id><pub-id pub-id-type="pmid">29370315</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lack</surname><given-names>NA</given-names></name><name><surname>Yam</surname><given-names>KC</given-names></name><name><surname>Lowe</surname><given-names>ED</given-names></name><name><surname>Horsman</surname><given-names>GP</given-names></name><name><surname>Owen</surname><given-names>RL</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name><name><surname>Eltis</surname><given-names>LD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Characterization of a carbon-carbon hydrolase from <italic>Mycobacterium tuberculosis</italic> involved in cholesterol metabolism</article-title><source>The Journal of Biological Chemistry</source><volume>285</volume><fpage>434</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.058081</pub-id><pub-id pub-id-type="pmid">19875455</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larigauderie</surname><given-names>G</given-names></name><name><surname>Furman</surname><given-names>C</given-names></name><name><surname>Jaye</surname><given-names>M</given-names></name><name><surname>Lasselin</surname><given-names>C</given-names></name><name><surname>Copin</surname><given-names>C</given-names></name><name><surname>Fruchart</surname><given-names>J-C</given-names></name><name><surname>Castro</surname><given-names>G</given-names></name><name><surname>Rouis</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>24</volume><fpage>504</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.0000115638.27381.97</pub-id><pub-id pub-id-type="pmid">14707038</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>VanderVen</surname><given-names>BC</given-names></name><name><surname>Fahey</surname><given-names>RJ</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Intracellular <italic>Mycobacterium tuberculosis</italic> exploits host-derived fatty acids to limit metabolic stress</article-title><source>The Journal of Biological Chemistry</source><volume>288</volume><fpage>6788</fpage><lpage>6800</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.445056</pub-id><pub-id pub-id-type="pmid">23306194</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>JF</given-names></name><name><surname>Pi</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Roles of HIF-1α signaling in <italic>Mycobacterium tuberculosis</italic> infection: New targets for anti-TB therapeutics?</article-title><source>Biochemical and Biophysical Research Communications</source><volume>711</volume><elocation-id>e149920</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2024.149920</pub-id><pub-id pub-id-type="pmid">38615574</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Listenberger</surname><given-names>LL</given-names></name><name><surname>Brown</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Fluorescent detection of lipid droplets and associated proteins</article-title><source>Current Protocols in Cell Biology</source><volume>Chapter 24</volume><elocation-id>Unit</elocation-id><pub-id pub-id-type="doi">10.1002/0471143030.cb2402s35</pub-id><pub-id pub-id-type="pmid">18228510</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lott</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The tryptophan biosynthetic pathway is essential for <italic>Mycobacterium tuberculosis</italic> to cause disease</article-title><source>Biochemical Society Transactions</source><volume>48</volume><fpage>2029</fpage><lpage>2037</lpage><pub-id pub-id-type="doi">10.1042/BST20200194</pub-id><pub-id pub-id-type="pmid">32915193</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsufuji</surname><given-names>T</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Naito</surname><given-names>A</given-names></name><name><surname>Hirouchi</surname><given-names>M</given-names></name><name><surname>Kanda</surname><given-names>S</given-names></name><name><surname>Izumi</surname><given-names>M</given-names></name><name><surname>Harada</surname><given-names>J</given-names></name><name><surname>Shinozuka</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Arylpiperazines as fatty acid transport protein 1 (FATP1) inhibitors with improved potency and pharmacokinetic properties</article-title><source>Bioorganic &amp; Medicinal Chemistry Letters</source><volume>23</volume><fpage>2560</fpage><lpage>2565</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2013.02.116</pub-id><pub-id pub-id-type="pmid">23528296</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinney</surname><given-names>JD</given-names></name><name><surname>Höner zu Bentrup</surname><given-names>K</given-names></name><name><surname>Muñoz-Elías</surname><given-names>EJ</given-names></name><name><surname>Miczak</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Chan</surname><given-names>WT</given-names></name><name><surname>Swenson</surname><given-names>D</given-names></name><name><surname>Sacchettini</surname><given-names>JC</given-names></name><name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Persistence of <italic>Mycobacterium tuberculosis</italic> in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase</article-title><source>Nature</source><volume>406</volume><fpage>735</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1038/35021074</pub-id><pub-id pub-id-type="pmid">10963599</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muñoz-Elías</surname><given-names>EJ</given-names></name><name><surname>McKinney</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title><italic>Mycobacterium tuberculosis</italic> isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence</article-title><source>Nature Medicine</source><volume>11</volume><fpage>638</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1038/nm1252</pub-id><pub-id pub-id-type="pmid">15895072</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muñoz-Elías</surname><given-names>EJ</given-names></name><name><surname>Upton</surname><given-names>AM</given-names></name><name><surname>Cherian</surname><given-names>J</given-names></name><name><surname>McKinney</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Role of the methylcitrate cycle in <italic>Mycobacterium tuberculosis</italic> metabolism, intracellular growth, and virulence</article-title><source>Molecular Microbiology</source><volume>60</volume><fpage>1109</fpage><lpage>1122</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05155.x</pub-id><pub-id pub-id-type="pmid">16689789</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiyama</surname><given-names>K</given-names></name><name><surname>Fujita</surname><given-names>T</given-names></name><name><surname>Fujimoto</surname><given-names>Y</given-names></name><name><surname>Nakajima</surname><given-names>H</given-names></name><name><surname>Takeuchi</surname><given-names>T</given-names></name><name><surname>Azuma</surname><given-names>YT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fatty acid transport protein 1 enhances the macrophage inflammatory response by coupling with ceramide and c-Jun N-terminal kinase signaling</article-title><source>International Immunopharmacology</source><volume>55</volume><fpage>205</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2017.12.003</pub-id><pub-id pub-id-type="pmid">29272817</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouimet</surname><given-names>M</given-names></name><name><surname>Koster</surname><given-names>S</given-names></name><name><surname>Sakowski</surname><given-names>E</given-names></name><name><surname>Ramkhelawon</surname><given-names>B</given-names></name><name><surname>van Solingen</surname><given-names>C</given-names></name><name><surname>Oldebeken</surname><given-names>S</given-names></name><name><surname>Karunakaran</surname><given-names>D</given-names></name><name><surname>Portal-Celhay</surname><given-names>C</given-names></name><name><surname>Sheedy</surname><given-names>FJ</given-names></name><name><surname>Ray</surname><given-names>TD</given-names></name><name><surname>Cecchini</surname><given-names>K</given-names></name><name><surname>Zamore</surname><given-names>PD</given-names></name><name><surname>Rayner</surname><given-names>KJ</given-names></name><name><surname>Marcel</surname><given-names>YL</given-names></name><name><surname>Philips</surname><given-names>JA</given-names></name><name><surname>Moore</surname><given-names>KJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>Mycobacterium tuberculosis</italic> induces the miR-33 locus to reprogram autophagy and host lipid metabolism</article-title><source>Nature Immunology</source><volume>17</volume><fpage>677</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1038/ni.3434</pub-id><pub-id pub-id-type="pmid">27089382</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>AK</given-names></name><name><surname>Sassetti</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mycobacterial persistence requires the utilization of host cholesterol</article-title><source>PNAS</source><volume>105</volume><fpage>4376</fpage><lpage>4380</lpage><pub-id pub-id-type="doi">10.1073/pnas.0711159105</pub-id><pub-id pub-id-type="pmid">18334639</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parihar</surname><given-names>SP</given-names></name><name><surname>Guler</surname><given-names>R</given-names></name><name><surname>Khutlang</surname><given-names>R</given-names></name><name><surname>Lang</surname><given-names>DM</given-names></name><name><surname>Hurdayal</surname><given-names>R</given-names></name><name><surname>Mhlanga</surname><given-names>MM</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Marais</surname><given-names>AD</given-names></name><name><surname>Brombacher</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Statin therapy reduces the <italic>Mycobacterium tuberculosis</italic> burden in human macrophages and in mice by enhancing autophagy and phagosome maturation</article-title><source>The Journal of Infectious Diseases</source><volume>209</volume><fpage>754</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1093/infdis/jit550</pub-id><pub-id pub-id-type="pmid">24133190</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>BH-J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Yechoor</surname><given-names>VK</given-names></name><name><surname>Chan</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Deficiency of adipose differentiation-related protein impairs foam cell formation and protects against atherosclerosis</article-title><source>Circulation Research</source><volume>102</volume><fpage>1492</fpage><lpage>1501</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.168070</pub-id><pub-id pub-id-type="pmid">18483409</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peyron</surname><given-names>P</given-names></name><name><surname>Vaubourgeix</surname><given-names>J</given-names></name><name><surname>Poquet</surname><given-names>Y</given-names></name><name><surname>Levillain</surname><given-names>F</given-names></name><name><surname>Botanch</surname><given-names>C</given-names></name><name><surname>Bardou</surname><given-names>F</given-names></name><name><surname>Daffé</surname><given-names>M</given-names></name><name><surname>Emile</surname><given-names>J-F</given-names></name><name><surname>Marchou</surname><given-names>B</given-names></name><name><surname>Cardona</surname><given-names>P-J</given-names></name><name><surname>de Chastellier</surname><given-names>C</given-names></name><name><surname>Altare</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Foamy macrophages from tuberculous patients’ granulomas constitute a nutrient-rich reservoir for <italic>M. tuberculosis</italic> persistence</article-title><source>PLOS Pathogens</source><volume>4</volume><elocation-id>e1000204</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000204</pub-id><pub-id pub-id-type="pmid">19002241</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pisu</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Grenier</surname><given-names>JK</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Dual RNA-Seq of Mtb-infected macrophages in vivo reveals ontologically distinct host-pathogen interactions</article-title><source>Cell Reports</source><volume>30</volume><fpage>335</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.12.033</pub-id><pub-id pub-id-type="pmid">31940480</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pisu</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Narang</surname><given-names>V</given-names></name><name><surname>Theriault</surname><given-names>M</given-names></name><name><surname>Lê-Bury</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Lakudzala</surname><given-names>AE</given-names></name><name><surname>Mzinza</surname><given-names>DT</given-names></name><name><surname>Mhango</surname><given-names>DV</given-names></name><name><surname>Mitini-Nkhoma</surname><given-names>SC</given-names></name><name><surname>Jambo</surname><given-names>KC</given-names></name><name><surname>Singhal</surname><given-names>A</given-names></name><name><surname>Mwandumba</surname><given-names>HC</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single cell analysis of <italic>M. tuberculosis</italic> phenotype and macrophage lineages in the infected lung</article-title><source>The Journal of Experimental Medicine</source><volume>218</volume><elocation-id>e20210615</elocation-id><pub-id pub-id-type="doi">10.1084/jem.20210615</pub-id><pub-id pub-id-type="pmid">34292313</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Podinovskaia</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>Caldwell</surname><given-names>S</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Infection of macrophages with <italic>Mycobacterium tuberculosis</italic> induces global modifications to phagosomal function</article-title><source>Cellular Microbiology</source><volume>15</volume><fpage>843</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1111/cmi.12092</pub-id><pub-id pub-id-type="pmid">23253353</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raggers</surname><given-names>RJ</given-names></name><name><surname>van Helvoort</surname><given-names>A</given-names></name><name><surname>Evers</surname><given-names>R</given-names></name><name><surname>van Meer</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane</article-title><source>Journal of Cell Science</source><volume>112 (Pt 3)</volume><fpage>415</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1242/jcs.112.3.415</pub-id><pub-id pub-id-type="pmid">9885294</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>DG</given-names></name><name><surname>Cardona</surname><given-names>PJ</given-names></name><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Allain</surname><given-names>S</given-names></name><name><surname>Altare</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Foamy macrophages and the progression of the human tuberculosis granuloma</article-title><source>Nature Immunology</source><volume>10</volume><fpage>943</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1038/ni.1781</pub-id><pub-id pub-id-type="pmid">19692995</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savvi</surname><given-names>S</given-names></name><name><surname>Warner</surname><given-names>DF</given-names></name><name><surname>Kana</surname><given-names>BD</given-names></name><name><surname>McKinney</surname><given-names>JD</given-names></name><name><surname>Mizrahi</surname><given-names>V</given-names></name><name><surname>Dawes</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Functional characterization of a vitamin B12-dependent methylmalonyl pathway in <italic>Mycobacterium tuberculosis</italic>: implications for propionate metabolism during growth on fatty acids</article-title><source>Journal of Bacteriology</source><volume>190</volume><fpage>3886</fpage><lpage>3895</lpage><pub-id pub-id-type="doi">10.1128/JB.01767-07</pub-id><pub-id pub-id-type="pmid">18375549</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnappinger</surname><given-names>D</given-names></name><name><surname>Ehrt</surname><given-names>S</given-names></name><name><surname>Voskuil</surname><given-names>MI</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Mangan</surname><given-names>JA</given-names></name><name><surname>Monahan</surname><given-names>IM</given-names></name><name><surname>Dolganov</surname><given-names>G</given-names></name><name><surname>Efron</surname><given-names>B</given-names></name><name><surname>Butcher</surname><given-names>PD</given-names></name><name><surname>Nathan</surname><given-names>C</given-names></name><name><surname>Schoolnik</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Transcriptional adaptation of <italic>Mycobacterium tuberculosis</italic> within macrophages: insights into the phagosomal environment</article-title><source>The Journal of Experimental Medicine</source><volume>198</volume><fpage>693</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1084/jem.20030846</pub-id><pub-id pub-id-type="pmid">12953091</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Salamon</surname><given-names>H</given-names></name><name><surname>Eugenin</surname><given-names>EA</given-names></name><name><surname>Pine</surname><given-names>R</given-names></name><name><surname>Cooper</surname><given-names>A</given-names></name><name><surname>Gennaro</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Infection with <italic>Mycobacterium tuberculosis</italic> induces the Warburg effect in mouse lungs</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>18176</elocation-id><pub-id pub-id-type="doi">10.1038/srep18176</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simwela</surname><given-names>NV</given-names></name><name><surname>Johnston</surname><given-names>L</given-names></name><name><surname>Bitar</surname><given-names>PP</given-names></name><name><surname>Jaecklein</surname><given-names>E</given-names></name><name><surname>Altier</surname><given-names>C</given-names></name><name><surname>Sassetti</surname><given-names>CM</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Genome-wide screen of <italic>Mycobacterium tuberculosis</italic>-infected macrophages revealed GID/CTLH complex-mediated modulation of bacterial growth</article-title><source>Nature Communications</source><volume>15</volume><elocation-id>9322</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-024-53637-z</pub-id><pub-id pub-id-type="pmid">39472457</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Jamwal</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Verma</surname><given-names>P</given-names></name><name><surname>Gokhale</surname><given-names>R</given-names></name><name><surname>Rao</surname><given-names>KVS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title><italic>Mycobacterium tuberculosis</italic>-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype</article-title><source>Cell Host &amp; Microbe</source><volume>12</volume><fpage>669</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2012.09.012</pub-id><pub-id pub-id-type="pmid">23159056</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singhal</surname><given-names>A</given-names></name><name><surname>Jie</surname><given-names>L</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Hong</surname><given-names>GS</given-names></name><name><surname>Leow</surname><given-names>MK-S</given-names></name><name><surname>Paleja</surname><given-names>B</given-names></name><name><surname>Tsenova</surname><given-names>L</given-names></name><name><surname>Kurepina</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zolezzi</surname><given-names>F</given-names></name><name><surname>Kreiswirth</surname><given-names>B</given-names></name><name><surname>Poidinger</surname><given-names>M</given-names></name><name><surname>Chee</surname><given-names>C</given-names></name><name><surname>Kaplan</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name><name><surname>De Libero</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Metformin as adjunct antituberculosis therapy</article-title><source>Science Translational Medicine</source><volume>6</volume><elocation-id>263ra159</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3009885</pub-id><pub-id pub-id-type="pmid">25411472</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theriault</surname><given-names>ME</given-names></name><name><surname>Pisu</surname><given-names>D</given-names></name><name><surname>Wilburn</surname><given-names>KM</given-names></name><name><surname>Lê-Bury</surname><given-names>G</given-names></name><name><surname>MacNamara</surname><given-names>CW</given-names></name><name><surname>Michael Petrassi</surname><given-names>H</given-names></name><name><surname>Love</surname><given-names>M</given-names></name><name><surname>Rock</surname><given-names>JM</given-names></name><name><surname>VanderVen</surname><given-names>BC</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Iron limitation in <italic>M. tuberculosis</italic> has broad impact on central carbon metabolism</article-title><source>Communications Biology</source><volume>5</volume><elocation-id>685</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-022-03650-z</pub-id><pub-id pub-id-type="pmid">35810253</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogel</surname><given-names>A</given-names></name><name><surname>Brunner</surname><given-names>JS</given-names></name><name><surname>Hajto</surname><given-names>A</given-names></name><name><surname>Sharif</surname><given-names>O</given-names></name><name><surname>Schabbauer</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Lipid scavenging macrophages and inflammation</article-title><source>Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids</source><volume>1867</volume><elocation-id>159066</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbalip.2021.159066</pub-id><pub-id pub-id-type="pmid">34626791</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname><given-names>DF</given-names></name><name><surname>Evans</surname><given-names>JC</given-names></name><name><surname>Mizrahi</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Nucleotide metabolism and DNA replication</article-title><source>Microbiology Spectrum</source><volume>2</volume><elocation-id>e2013</elocation-id><pub-id pub-id-type="doi">10.1128/microbiolspec.MGM2-0001-2013</pub-id><pub-id pub-id-type="pmid">26104350</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="report"><person-group person-group-type="author"><collab>WHO</collab></person-group><year iso-8601-date="2023">2023</year><source>Global Tuberculosis Report 2023</source><publisher-loc>Geneva</publisher-loc><publisher-name>Switzerland World Health Organisation</publisher-name></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilburn</surname><given-names>KM</given-names></name><name><surname>Fieweger</surname><given-names>RA</given-names></name><name><surname>VanderVen</surname><given-names>BC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cholesterol and fatty acids grease the wheels of <italic>Mycobacterium tuberculosis</italic> pathogenesis</article-title><source>Pathogens and Disease</source><volume>76</volume><elocation-id>fty021</elocation-id><pub-id pub-id-type="doi">10.1093/femspd/fty021</pub-id><pub-id pub-id-type="pmid">29718271</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>AJ</given-names></name><name><surname>Linas</surname><given-names>B</given-names></name><name><surname>Trevejo-Nuñez</surname><given-names>GJ</given-names></name><name><surname>Kincaid</surname><given-names>E</given-names></name><name><surname>Tamura</surname><given-names>T</given-names></name><name><surname>Takatsu</surname><given-names>K</given-names></name><name><surname>Ernst</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title><italic>Mycobacterium tuberculosis</italic> infects dendritic cells with high frequency and impairs their function in vivo</article-title><source>Journal of Immunology</source><volume>179</volume><fpage>2509</fpage><lpage>2519</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.4.2509</pub-id><pub-id pub-id-type="pmid">17675513</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>P</given-names></name><name><surname>Dai</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Bo</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>clusterProfiler 4.0: a universal enrichment tool for interpreting omics data</article-title><source>Innovation</source><volume>2</volume><elocation-id>100141</elocation-id><pub-id pub-id-type="doi">10.1016/j.xinn.2021.100141</pub-id><pub-id pub-id-type="pmid">34557778</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zahrt</surname><given-names>TC</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Siple</surname><given-names>J</given-names></name><name><surname>Deretic</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Mycobacterial FurA is a negative regulator of catalase-peroxidase gene katG</article-title><source>Molecular Microbiology</source><volume>39</volume><fpage>1174</fpage><lpage>1185</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2001.02321.x</pub-id><pub-id pub-id-type="pmid">11251835</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102980.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University</institution><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study reveals that disrupting fatty acid metabolism in macrophages significantly restricts the growth of <italic>Mycobacterium tuberculosis</italic>, showing that impaired lipid processing triggers various antimicrobial responses. Overall, the approach is robust utilizing CRISPR-Cas9 knockout of multiple genes involved in lipid metabolism that yielded <bold>convincing</bold> data. This work highlights how host lipid metabolism affects the ability of tubercle bacilli to thrive intracellularly, pointing to potential new therapeutic targets.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102980.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This study investigates the role of macrophage lipid metabolism in the intracellular growth of <italic>Mycobacterium tuberculosis</italic>. By using a CRISPR-Cas9 gene-editing approach, the authors knocked out key genes involved in fatty acid import, lipid droplet formation, and fatty acid oxidation in macrophages. Their results show that disrupting various stages of fatty acid metabolism significantly impairs the ability of Mtb to replicate inside macrophages. The mechanisms of growth restriction included increased glycolysis, oxidative stress, pro-inflammatory cytokine production, enhanced autophagy, and nutrient limitation. The study demonstrates that targeting fatty acid homeostasis at different stages of the lipid metabolic process could offer new strategies for host-directed therapies against tuberculosis.</p><p>The work is convincing and methodologically strong, combining genetic, metabolic, and transcriptomic analyses to provide deep insights into how host lipid metabolism affects bacterial survival.</p><p>Strengths:</p><p>The study uses a multifaceted approach, including CRISPR-Cas9 gene knockouts, metabolic assays, and dual RNA sequencing, to assess how various stages of macrophage lipid metabolism affect Mtb growth. The use of CRISPR-Cas9 to selectively knock out key genes involved in fatty acid metabolism enables precise investigation of how each step-lipid import, lipid droplet formation, and fatty acid oxidation-affects Mtb survival. The study offers mechanistic insights into how different impairments in lipid metabolism lead to diverse antimicrobial responses, including glycolysis, oxidative stress, and autophagy. This deepens the understanding of macrophage function in immune defense.</p><p>The use of functional assays to validate findings (e.g., metabolic flux analyses, lipid droplet formation assays, and rescue experiments with fatty acid supplementation) strengthens the reliability and applicability of the results.</p><p>By highlighting potential targets for HDT that exploit macrophage lipid metabolism to restrict Mtb growth, the work has significant implications for developing new tuberculosis treatments.</p><p>Weaknesses:</p><p>The experiments were primarily conducted in vitro using CRISPR-modified macrophages. While these provide valuable insights, they may not fully replicate the complexity of the in vivo environment where multiple cell types and factors influence Mtb infection and immune responses. Yet, I agree that the Hoxb8 in vitro model provides a powerful genetic tool to interrogate host-Mtb interactions using primary macrophages that represent the bone marrow-derived macrophage lineage, instead of using cell lines.</p><p>Comments on revisions: The authors have addressed my comment satisfactorily.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102980.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Host-derived lipids are an important factor during Mtb infection. In this study, using CRISPR knockouts of genes involved in fatty acid uptake and metabolism, the authors claim that a compromised uptake, storage or metabolism of fatty acid in the hosts restricts Mtb growth upon infection. The mechanism involves increased glycolysis, autophagy, oxidative stress, pro-inflammatory cytokines and nutrient limitation. The study may be useful for developing novel host-directed approaches against TB.</p><p>Strengths:</p><p>The study's strength is the use of clean HOXB8-derived primary mouse macrophage lines for generating CRISPR knockouts.</p><p>Weaknesses:</p><p>The strength of evidence on autophagy and redox stress remains incomplete.</p><p>Comments on revisions:</p><p>The authors have revised the manuscript and addressed some of the earlier concerns. However, some of the interpretations and responses are incorrect.</p><p>Overall, the level of evidence to state the following in the abstract- ‘Our analyzes demonstrate that macrophages which cannot either import, store or catabolize fatty acids restrict Mtb growth by both common and divergent anti-microbial mechanisms, including increased glycolysis, increased oxidative stress, production of pro-inflammatory cytokines, enhanced autophagy and nutrient limitation’ is incomplete.</p><p>There is an increase in glycolysis and pro-inflammatory cytokines and, to some extent, oxidative stress. The same can not be said about autophagy. Unfortunately, the authors did not try to establish a direct role of any of these pathways in restricting bacterial growth in the absence of any of the three genes studied.</p><p>Major concern:</p><p>Autophagy: The LC3 WB does not, by any stretch of the imagination, convince that there is an increase in autophagy flux, as inferred by the authors. Authors correctly cite the ‘Guidelines to autophagy’ paper. Unfortunately, they cite it only selectively to justify their assessment. The LC3II/LC3I ratio indicates the number of autophagosomes present. This ratio can also increase if there is an active block of autophagosome maturation. That's why having BafA1 or CQ controls is important to assess the active autophagosome maturation. However, the authors sidestep this serious consideration by claiming some ‘pleiotropic impact on Mtb’. With BafA1 and CQ, the only assay one needs is to measure the impact on LC3II levels. In the absence of this assay, the evidence supporting the role of autophagy is incomplete.</p><p>The main concern regarding autophagy results is that autophagy induction can typically bring down oxidative stress and classically has anti-inflammatory outlay. Thus, increased glycolysis, inflammatory cytokine production and redox stress indicate more towards a potential block in autophagy at the maturation step. This necessitates validation using autophagy flux assays.</p><p>Oxidative stress: Showing a representative image for the corresponding representative groups would be more convincing. For example, there is no clarity on whether, in the infected group, there was any staining for Mtb to analyse only the infected cells.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102980.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This study provides significant insights into how host metabolism, specifically of lipids, influences the pathogenesis of <italic>Mycobacterium tuberculosis</italic> (Mtb). It builds on existing knowledge about Mtb's reliance on host lipids and emphasizes the potential of targeting fatty acid metabolism for therapeutic intervention.</p><p>Strengths:</p><p>To generate the data, the authors use CRISPR technology to precisely disrupt the genes involved in lipid import (CD36, FATP1), lipid droplet formation (PLIN2) and fatty acid oxidation (CPT1A, CPT2) in mouse primary macrophages. The Mtb Erdman strain is used to infect the macrophage mutants. The study, revealsspecific roles of different lipid-related genes. Importantly, results challenge previous assumptions about lipid droplet formation and show that macrophage responses to lipid metabolism impairments are complex and multifaceted. The experiments are well-controlled and the data is convincing.</p><p>Overall, this well-written paper makes a meaningful contribution to the field of tuberculosis research, particularly in the context of host-directed therapies (HDTs). It suggests that manipulating macrophage metabolism could be an effective strategy to limit Mtb growth.</p><p>Weaknesses:</p><p>None noted. The manuscript provides important new knowledge that will lead mpvel to host-directed therapies to control Mtb infections.</p><p>Comments on revisions: The authors have addressed the concerns of the reviewers.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102980.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Simwela</surname><given-names>Nelson V</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05bnh6r87</institution-id><institution>Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University</institution></institution-wrap><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Jaecklein</surname><given-names>Eleni</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0464eyp60</institution-id><institution>Department of Microbiology, UMass Chan Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Worcester</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Sassetti</surname><given-names>Christopher M</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0464eyp60</institution-id><institution>Department of Microbiology, UMass Chan Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Worcester</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Russell</surname><given-names>David</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05bnh6r87</institution-id><institution>Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University</institution></institution-wrap><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public review):</bold></p><p>Summary:</p><p>This study investigates the role of macrophage lipid metabolism in the intracellular growth of <italic>Mycobacterium tuberculosis</italic>. By using a CRISPR-Cas9 gene-editing approach, the authors knocked out key genes involved in fatty acid import, lipid droplet formation, and fatty acid oxidation in macrophages. Their results show that disrupting various stages of fatty acid metabolism significantly impairs the ability of Mtb to replicate inside macrophages. The mechanisms of growth restriction included increased glycolysis, oxidative stress, pro-inflammatory cytokine production, enhanced autophagy, and nutrient limitation. The study demonstrates that targeting fatty acid homeostasis at different stages of the lipid metabolic process could offer new strategies for host-directed therapies against tuberculosis.</p><p>The work is convincing and methodologically strong, combining genetic, metabolic, and transcriptomic analyses to provide deep insights into how host lipid metabolism affects bacterial survival.</p><p>Strengths:</p><p>The study uses a multifaceted approach, including CRISPR-Cas9 gene knockouts, metabolic assays, and dual RNA sequencing, to assess how various stages of macrophage lipid metabolism affect Mtb growth. The use of CRISPR-Cas9 to selectively knock out key genes involved in fatty acid metabolism enables precise investigation of how each step-lipid import, lipid droplet formation, and fatty acid oxidation affect Mtb survival. The study offers mechanistic insights into how different impairments in lipid metabolism lead to diverse antimicrobial responses, including glycolysis, oxidative stress, and autophagy. This deepens the understanding of macrophage function in immune defense.</p><p>The use of functional assays to validate findings (e.g., metabolic flux analyses, lipid droplet formation assays, and rescue experiments with fatty acid supplementation) strengthens the reliability and applicability of the results.</p><p>By highlighting potential targets for HDT that exploit macrophage lipid metabolism to restrict Mtb growth, the work has significant implications for developing new tuberculosis treatments.</p><p>Weaknesses:</p><p>The experiments were primarily conducted in vitro using CRISPR-modified macrophages. While these provide valuable insights, they may not fully replicate the complexity of the in vivo environment where multiple cell types and factors influence Mtb infection and immune responses.</p></disp-quote><p>We thank the reviewer for pointing this out. We acknowledge that our in vitro system may indeed not fully replicate the complex in vivo environment given of what is becoming to light of macrophage heterogenous responses to Mtb infection in whole animal models. We do believe, however, that the Hoxb8 in vitro model provides a powerful genetic tool to interrogate host-Mtb interactions using primary macrophages that represent the bone marrow-derived macrophage lineage.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>Summary:</p><p>Host-derived lipids are an important factor during Mtb infection. In this study, using CRISPR knockouts of genes involved in fatty acid uptake and metabolism, the authors claim that a compromised uptake, storage, or metabolism of fatty acid restricts Mtb growth upon infection. Further, the authors claim that the mechanism involves increased glycolysis, autophagy, oxidative stress, pro-inflammatory cytokines, and nutrient limitation. The authors also claim that impaired lipid droplet formation restricts Mtb growth. However, promoting lipid droplet biogenesis does not reverse/promote Mtb growth.</p><p>Strengths:</p><p>The strength of the study is the use of clean HOXB8-derived primary mouse macrophage lines for generating CRISPR knockouts.</p><p>Weaknesses:</p><p>There are many weaknesses of this study, they are clubbed into four categories below</p><p>(1) Evidence and interpretations: The results shown in this study at several places do not support the interpretations made or are internally contradictory or inconsistent. There are several important observations, but none were taken forward for in-depth analysis.</p><p>a) The phenotypes of PLIN2<sup>-/-</sup>, FATP1<sup>-/-</sup>, and CPT-/- are comparable in terms of bacterial growth restriction; however, their phenotype in terms of lipid body formation, IL1B expression, etc., are not consistent. These are interesting observations and suggest additional mechanisms specific to specific target genes; however, clubbing them all as altered fatty acid uptake or catabolism-dependent phenotypes takes away this important point.</p></disp-quote><p>We thank the reviewer for highlighting this. Our focus was on assessing the impact of manipulating lipid homeostasis in macrophages at several stages and the consequences this has on the intracellular growth of Mtb. Throughout the manuscript (abstract, results and discussion), we have continuously emphasized that interfering with lipid handling at several stages in macrophages results in both conserved and divergent antimicrobial responses against intracellular Mtb.</p><disp-quote content-type="editor-comment"><p>b) Finding the FATP1 transcript in the HOXB8-derived FATP1<sup>-/-</sup> CRISPR KO line is a bit confusing. There is less than a two-fold decrease in relative transcript abundance in the KO line compared to the WT line, leaving concerns regarding the robustness of other experiments as well using FATP1<sup>-/-</sup> cells.</p></disp-quote><p>CRISPR-Cas9 targeting of genes with single sgRNAs as is the case with our mutants generates insertions and deletions (INDELs) at the CRISPR cut site. These INDELs do not block mRNA transcription totally, and this is widely reported in the field. Because of this, quantitative RT-PCR or RNA-seq methods are not routinely used to verify CRISPR knockouts as they are not sensitive enough to identify INDELs. We provide INDEL quantification and knockout efficiencies by ICE analysis in supplemental file 1 for all the mutants used in the study. We also demonstrate protein depletion by western blot and flow cytometry for all the mutants (Figure 1 - figure supplement 1). Only mutants with greater than &gt;90% protein depletion were used for subsequent characterization.</p><disp-quote content-type="editor-comment"><p>c) No gene showing differential regulation in FATP<sup>-/-</sup> macrophages, which is very surprising.</p></disp-quote><p>We assume the reviewer is referring to the Mtb transcriptome response in FATP1<sup>-/-</sup> macrophages, which we agree was unexpected. However, we saw a significant compensatory response in the host cell (at transcriptional level) in FATP1<sup>-/-</sup> macrophages as evidenced by an upregulation of other fatty acid transporters (Figure 5 - figure supplement 1, now Figure 6 - figure supplement 1). We believe that these compensatory responses could, in part, alleviate the stresses the bacteria experience within the cell. We discuss this point in the manuscript.</p><disp-quote content-type="editor-comment"><p>d) ROS measurements should be done using flow cytometry and not by microscopy to nail the actual pattern.</p></disp-quote><p>We thank the reviewer for the suggestion. However, confocal imaging is also widely used to measure ROS with similar quantitative power and individual cell resolution (PMID: 32636249, 35737799).</p><disp-quote content-type="editor-comment"><p>(2) Experimental design: For a few assays, the experimental design is inappropriate</p><p>a) For autophagy flux assay, immunoblot of LC3II alone is not sufficient to make any interpretation regarding the state of autophagy. This assay must be done with BafA1 or CQ controls to assess the true state of autophagy.</p></disp-quote><p>We would like to point out that monitoring LC3I to LC3II conversion by western blot, confocal imaging of LC3 puncta and qPCR analysis of autophagy related genes are all validated assays for monitoring autophagic flux in a wide variety of cells. We refer the reviewer to the latest extensive guidelines on the subject (PMID: 33634751). Furthermore, Bafilomycin A and chloroquine are not specific inhibitors of autophagy and therefore are of limited value as controls. BafA is an inhibitor of the proton-ATPase apparatus and can indirectly impact autophagy through activity on the Ca-P60A/SERCA pathway. Chloroquine impacts vacuole acidification, autophagosome/lysosome fusion and slows phagosome maturation. So, while BafA and chloroquine will reduce autophagy; their effects are pleotropic and their impact on Mtb is unknown.</p><disp-quote content-type="editor-comment"><p>b) Similarly, qPCR analyses of autophagy-related gene expression do not reflect anything on the state of autophagy flux.</p></disp-quote><p>See our response above.</p><disp-quote content-type="editor-comment"><p>(3) Using correlative observations as evidence:</p><p>a) Observations based on RNAseq analyses are presented as functional readouts, which is incorrect.</p></disp-quote><p>We are not entirely sure where we used our RNA-seq data sets as functional readouts. We used our transcriptome data to provide a preliminary identification of anti-microbial responses in the mutant macrophages infected with Mtb and we mention this at the beginning of the RNA-seq results sections. Where applicable, we followed up and confirmed the more compelling RNA-seq data either by metabolic flux analyzes, qPCR, ROS measurements, and quantitative imaging.</p><disp-quote content-type="editor-comment"><p>b) Claiming that the inability to generate lipid droplets in PLIN2<sup>-/-</sup> cells led to the upregulation of several pathways in the cells is purely correlative, and the causal relationship does not exist in the data presented.</p></disp-quote><p>It was not our intention to infer causality. We have re-written the beginning of the sentence, and it now starts with ‘Meanwhile, Mtb infection of PLIN2<sup>-/-</sup> macrophages led to upregulation’ which hopefully eliminates any association to causality.</p><disp-quote content-type="editor-comment"><p>(4) Novelty: A few main observations described in this study were previously reported. That includes Mtb growth restriction in PLIN2 and FATP1 deficient cells. Similarly, the impact of Metformin and TMZ on intracellular Mtb growth is well-reported. While that validates these observations in this study, it takes away any novelty from the study.</p></disp-quote><p>To the best of our knowledge, Mtb growth restrictions in PLIN2 and FATP1 deficient macrophages have not been reported elsewhere. To the contrary, PLIN2 knockout macrophages obtained from PLIN2 deficient mice have been reported to robustly support Mtb replication (PMID: 29370315). We extensively discuss these discrepancies in the manuscript. We also discuss and cite appropriate references where Mtb growth restriction for similar macrophage mutants have been reported (CD36<sup>-/-</sup> and CPT2<sup>-/-</sup>). Our aim was to carry out a systematic myeloid specific genetic interference of fatty acid import, storage and catabolism to assess the effect on Mtb growth at all stages of lipid handling instead of focusing on one target. In the chemical approach, we used TMZ and Metformin deliberately because they had already been reported as being active against intracellular Mtb and we wished to place our data in the context of existing literature. These studies have been referenced extensively in the text.</p><disp-quote content-type="editor-comment"><p>(5) Manuscript organisation: It will be very helpful to rearrange figures and supplementary figures.</p></disp-quote><p>New figures have been added, and existing ones have been re-arranged where necessary. See our responses to recommendations for authors.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public review):</bold></p><p>Summary:</p><p>This study provides significant insights into how host metabolism, specifically lipids, influences the pathogenesis of <italic>Mycobacterium tuberculosis</italic> (Mtb). It builds on existing knowledge about Mtb's reliance on host lipids and emphasizes the potential of targeting fatty acid metabolism for therapeutic intervention.</p><p>Strengths:</p><p>To generate the data, the authors use CRISPR technology to precisely disrupt the genes involved in lipid import (CD36, FATP1), lipid droplet formation (PLIN2), and fatty acid oxidation (CPT1A, CPT2) in mouse primary macrophages. The Mtb Erdman strain is used to infect the macrophage mutants. The study, reveals specific roles of different lipid-related genes. Importantly, results challenge previous assumptions about lipid droplet formation and show that macrophage responses to lipid metabolism impairments are complex and multifaceted. The experiments are well-controlled and the data is convincing.</p><p>Overall, this well-written paper makes a meaningful contribution to the field of tuberculosis research, particularly in the context of host-directed therapies (HDTs). It suggests that manipulating macrophage metabolism could be an effective strategy to limit Mtb growth.</p><p>Weaknesses:</p><p>None noted. The manuscript provides important new knowledge that will lead mpvel to host-directed therapies to control Mtb infections.</p><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewer #1 (Recommendations for the authors):</bold></p><p>The study presents compelling and well-supported conclusions based on a solid body of evidence. However, the clarity of several figures could be improved for better understanding.</p><p>(1) In Figure 1, panels B and C are referenced incorrectly in the text.</p></disp-quote><p>We thank the reviewer for identifying the error. This has now been corrected</p><disp-quote content-type="editor-comment"><p>(2) Figures 2 and S2 would benefit from being combined or reorganized to display the data related to infected and uninfected cells together, making it easier for the reader to interpret.</p></disp-quote><p>We thank the reviewer for the suggestion. However, we believe that combining the two figures would further complicate the merged figure making it even more difficult to interpret. We decided to highlight the mutant macrophage’s responses upon Mtb infection in Figure 2 and put the uninfected data sets in supplementary information given that the OCR and ECAR trends were similar and as expected in both infected and uninfected states.</p><disp-quote content-type="editor-comment"><p>(3) Figure 3 is mislabeled, with four panels shown in the figure, but only panels A and B are mentioned in both the text and the figure legend.</p></disp-quote><p>We thank the reviewer for the observation. Figure 3 has been extensively revised. We have included new blots, statistical comparisons and a corresponding new supplementary figure (Figure 3 - figure supplement 1). We have verified that the figure panels are labelled correctly and appropriately referenced in the manuscript text.</p><disp-quote content-type="editor-comment"><p>(4) Figure 5 is overly complex and difficult to interpret. Simplifying the figure, possibly by reducing the amount of data or breaking it into more digestible parts, would enhance its readability.</p></disp-quote><p>We thank the reviewer for the suggestion. We have separated the figure into two parts which are now Figure 5 for the PCA and Venn diagrams and Figure 6 for the pathway enrichment figure panels. We have increased the resolution of both figures in the revised manuscript to improve readability.</p><disp-quote content-type="editor-comment"><p>(5) Panel 6A is not particularly informative and could either be omitted with a more detailed explanation provided in the text, or replaced with a clearer visual representation, such as Venn diagrams, to improve data visualization.</p></disp-quote><p>We thank the reviewer for the suggestion. We have removed Figure 6A given that detailed explanation of the panel is already available in the manuscript text.</p><disp-quote content-type="editor-comment"><p>(6) Additionally, on line 309, the word ‘to’ is missing before ‘generate’.</p></disp-quote><p>We thank the reviewer for identifying this. This sentence has now been re-written to address some unintended inferences of causation in line with recommendations from reviewer 2.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors):</bold></p><p>(1) Manuscript Organisations: The manuscript is very poorly organised. Supplemental figures are labelled very unconventionally, and that creates much confusion in following the manuscript. Some of the results in the supplementary figures could be easily kept in the main figures, as it is difficult to compare plots between the main figures and the supple figures. The results of RNAseq experiments are impossible to follow with very small fonts. Overall, the figures are very casually organised and can certainly be improved.</p></disp-quote><p>We would like to clarify that supplemental figures are labelled and organized as is in line with the eLife formatting of supplemental figures. We deliberately put some redundant figures like Figure 2 - figure supplement 1 in supplementary information (see our response to reviewer 1 recommendations on the same). We have split the RNA-seq Figure 5 into two separate figures (now Figure 5 and 6) and increased their resolution to improve readability.</p><disp-quote content-type="editor-comment"><p>(2) Figure 3: Among the KO lines, only PLIN2<sup>-/-</sup> had a higher HIF1a level before infection. Infection surely leads to higher levels across the three cases.</p></disp-quote><p>We have generated replicate western blots and provide statistical quantitation for both HIF1a, AMPK and pAMPK. Figure 3 has now been revised extensively, replicate blots are in Figure 3 - figure supplement 1. We have updated the text to reflect the reviewer observation which was also consistent with our statistical quantification.</p><disp-quote content-type="editor-comment"><p>(3) pAMPK blots are of very poor quality. Without quantification, the trend mentioned in the text is not clearly visible.</p></disp-quote><p>We have provided two more replicate blots for AMPK/pAMPK and provide statistical quantification as described above.</p><disp-quote content-type="editor-comment"><p>(4) Line 230: Regarding autophagy flux, neither the data suggest what is interpreted nor is this experiment correctly done. LC3 WB and autophagy gene qPCR: Unfortunately, LC3 WB, the way it was done, does not tell anything about the state of autophagy in these cells. A very mild LC3II increase is noted in CPT2<sup>-/-</sup> cells upon infection; the rest of the others do not show any change. This assay is not done correctly. To interpret LC3II WB, one needs to include the Bafilomycin A1 control, usually +Baf and -Baf run in the adjacent wells in the gel. Similarly, qPCR results are not indicative of any increase in autophagy. Regulation of ATG7, MAP1LC3B, and ULK1 is more at the post-translational level than the transcriptional level.</p></disp-quote><p>We have provided an additional replicate blot together with statistical quantification of LC3II/LC3I ratios in the revised Figure 3 - figure supplement 2. Our quantifications remain consistent with our prior assertations in the manuscript text. See our response in the public review section concerning autophagy assays and the use of Baf or chloroquine as controls.</p><disp-quote content-type="editor-comment"><p>(5) Exogenous oleate fails to rescue the Mtb icl1-deficient mutant in FATP1<sup>-/-</sup>, PLIN2<sup>-/-</sup> and CPT2<sup>-/-</sup> macrophages: this result is confusing. Lipid uptake and metabolism have been the central players so far; however, here, the phenotypes of FATP1 and CPT2 in terms of lipid body accumulation are very distinct. Therefore, the assessment that Mtb growth inhibition is due to factors other than limited access to fatty acid is not consistent with the theme of the study.</p></disp-quote><p>Nutrient limitation is a distinct transcriptional signature of Mtb, at least in PLIN2<sup>-/-</sup> macrophages (Figure 7). We used the oleate supplementation assay with the Mtb Dicl1 mutant to assess whether nutrient restriction was the sole anti-microbial pathway against Mtb in the knockout macrophages. This would have been the case (to a certain extent) if the growth of the Mtb Dicl1 mutant was rescuable upon addition of exogenous oleate in the knockout macrophages. Our data clearly shows that this is not the case and that in addition to nutrient limitation, interference with lipid processing results in several other macrophage anti-microbial responses against the bacteria. We extensively discuss these points in the abstract, results and discussion sections of the manuscript.</p><disp-quote content-type="editor-comment"><p>(6) Line 309: ‘Meanwhile, inability generate lipid droplets in Mtb infected PLIN2<sup>-/-</sup> macrophages led to upregulation in pathways involved in ribosomal biology, MHC class 1 antigen presentation, canonical glycolysis, ATP metabolic processes and type 1 interferon responses (Figure 5C, Supplementary file 3).’ This is just a correlative observation. However, it is mentioned here as a causal mechanism.</p></disp-quote><p>We have revised this sentence to remove any unintended inference of causation.</p><disp-quote content-type="editor-comment"><p>(7) IL-1b is upregulated in FATP-/- macrophages, no effect in CPT2<sup>-/-</sup> macrophages, but downregulated in PLIN2<sup>-/-</sup> macrophages. Moreover, this effect is very transient, and by 24 hours, all these differences are lost. This suggests the mechanism of action, as their pro-bacterial function shown in Figure 1, is very distinct for different proteins, and FA metabolism is probably not the common denominator across these phenotypes.</p></disp-quote><p>We agree with the reviewer, and we extensively discuss this in the manuscript text (results and discussion). Clearly, they are shared anti-microbial responses across the mutants, but they are also points of divergence. We would like to further clarify that pro-inflammatory responses (IL-1b or IFN-B) in Mtb infected macrophages show a biphasic early upregulation (up to 8 hours of infection) followed by a rapid resolution phase (24-48 hours post infection). This is well reported in the literature (PMID: 30914513). It is common for pro-inflammatory gene expression differences to be temporary lost during the resolution phase (PMID: 30914513, 39472457). IL-1b expression profiles return to the 4-hour equivalent profile in Mtb infected FATP1<sup>-/-</sup> and PLIN2<sup>-/-</sup> macrophages 4 days post infection (Figure 6A, Figure 6 - figure supplement 2B, Supplementary file 2)</p><disp-quote content-type="editor-comment"><p>(8) It is very surprising that FATP-/- macrophages do not show any change in Mtb gene expression. The robustness of this experiment and analysis appears doubtful, given that the phenotype in terms of bacterial growth was clean.</p></disp-quote><p>See our response to this comment in the public reviews section</p><disp-quote content-type="editor-comment"><p>(9) Figure 5, Supplementary Figure 1: Among the FA transporters, authors also show data for FATP1. I am surprised to see FATP1 expression levels in the FATP1<sup>-/-</sup> cells. This puts into doubt every dataset using FATP-/- cells in this study.</p></disp-quote><p>See our response to this comment in the public reviews section</p><disp-quote content-type="editor-comment"><p>(10) Unfortunately, with the kind of evidence presented, it is far-fetched to claim that PLIN2<sup>-/-</sup> macrophages restrict Mtb growth by increasing ROS production. There is no evidence for this statement. The MFI units in Figure 6, Supplementary 1 are too small to extract meaningful interpretations. Moreover, the data appears to be arrived at by combining multiple technical replicates. Usually, flow cytometry data are more reliable for CellROX assays. Microscopy is not the technique of choice for this assay.</p></disp-quote><p>We would like to point out that MFIs are arbitrary units set to predetermined reference points. In our case, the reference was background fluorescence in CellROX unstained cells and cells stained with CellROX equivalent fluorophore conjugated isotype antibodies. We are not entirely sure what the reviewer means by ‘small’ in these contexts. And the data is not entirely from technical replicates. Reported MFIs are from three independent repeats with MFI reads of at least 30 cells per replicate. We have added this clarification in Figure 6 - figure supplement 1 legend, now Figure 7 - figure supplement 1. See our response in the public reviews section on the use of confocal microcopy to image and quantify ROS. Furthermore, the Mtb transcriptional response in PLIN2<sup>-/-</sup> and CPT2<sup>-/-</sup> macrophages is clearly indicative of increased oxidative stresses (Figure 7).</p><disp-quote content-type="editor-comment"><p>(11) The CFU results with Metformin and TMZ are on the expected lines, as published earlier by others. FATP1 In data is good and aligned with the knockout phenotype.</p></disp-quote><p>We thank the reviewer for the note.</p><disp-quote content-type="editor-comment"><p>(12) Western blots, when interpreted for quantitative differences, must be quantified, and data should be represented as plots with statistical analysis.</p></disp-quote><p>Replicate blots have been provided and statistical quantifications performed.</p></body></sub-article></article>